Medical observation and evaluation for suspected diseases and conditions

Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z03 Cause of death: ICD-10 — Z03 2 out of 7 registries used, show all original rules.	106301
4. Check minimum number of events None	106301
5. Include endpoints None	106301
6. Filter based on genotype QC (FinnGen only)	95427

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[0-1]

NAME	Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z03
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z03
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Medical observation and evaluation for suspected diseases and conditions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Other transitory neonatal electrolyte and metabolic disturbances

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	95427	56344	39083
Unadjusted period prevalence (%)	19.15	20.00	17.92
Median age at first event (years)	55.31	51.88	60.26

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
44492: Matched controls
227322

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

323.3

2315

4654

D11

ICPC

Diarrhoea

2.0

323.0

4598

12487

TAB00

NOMESCO Finland

Lumbar puncture

3.2

321.2

1626

2668

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

320.8

8127

26465

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.1

320.5

677

496

M48.0

ICD-10 Finland

Spinal stenosis

2.1

319.9

3873

9893

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

319.9

5259

15015

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

319.8

14324

53649

M79.7

ICD-10 Finland

Fibromyalgia

4.0

319.0

1182

1546

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.5

318.8

719

573

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

318.7

4072

10620

C10AA05

ATC

atorvastatin; oral

1.5

318.6

14173

52993

Z01.7

ICD-10 Finland

Laboratory examination

1.8

318.2

5949

17709

N06AX26

ATC

vortioxetine; oral

2.3

318.1

2985

6848

R96

ICPC

Asthma

2.2

317.5

3356

8110

A03

ICPC

Fever

1.8

317.0

6858

21343

U02

ICPC

Urinary frequency/urgency

1.9

316.6

4886

13649

J01DA01

ATC

[U] cefalexin

1.5

314.9

23660

98617

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

314.3

4624

12700

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

314.1

2315

4725

H03AA01

ATC

levothyroxine sodium; systemic

1.7

314.0

7630

24543

N01

ICPC

Headache

2.0

308.3

4420

12023

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

85.2

307.7

8683

645

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

60.8

307.7

1430

124

N05CF01

ATC

zopiclone; oral

1.9

307.7

12120

38236

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

307.7

4854

10390

T89

ICPC

Diabetes insulin dependent

3.7

307.7

1471

2057

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

307.7

11524

37284

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

5.6

307.7

2442

2317

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.6

307.7

1879

2715

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

307.7

16248

44636

R52.9

ICD-10 Finland

Pain, unspecified

2.3

307.7

4007

9303

J01CA04

ATC

amoxicillin; systemic

1.7

307.7

34093

150277

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

307.7

3959

8188

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

307.7

6592

17706

N05AX12

ATC

aripiprazole; systemic

3.2

307.7

1660

2716

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.1

307.7

1822

2353

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

307.7

4736

12243

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

17.4

307.7

1926

590

R51.80

ICD-10 Finland

Headache

2.8

307.7

6962

14260

N03AX09

ATC

lamotrigine; oral

4.1

307.7

2117

2729

Z01.2

ICD-10 Finland

Dental examination

1.6

307.7

18593

69406

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

307.7

3616

7889

N05AH04

ATC

quetiapine; oral

2.7

307.7

8178

17284

N30.0

ICD-10 Finland

Acute cystitis

1.9

307.7

6077

17693

XCH00

NOMESCO Finland

Eye pressure measurement

4.0

307.7

1564

2045

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.5

307.7

2170

3295

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

307.7

7878

24338

N03AX16

ATC

[U] pregabalin

2.6

307.7

9425

21087

L08

ICPC

Shoulder symptom/complaint

1.8

307.7

8150

25821

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

504.3

307.7

3291

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

80.6

307.7

3558

245

N02BF02

ATC

pregabalin; oral

2.7

307.7

2514

4938

R03AC02

ATC

salbutamol; inhalant

1.8

307.7

22374

80719

R01AD09

ATC

mometasone; nasal

1.6

307.7

17105

64845

N03AX12

ATC

[U] gabapentin; oral

2.7

307.7

6108

12775

J01FF01

ATC

clindamycin; systemic

1.9

307.7

10375

32055

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

307.7

29333

122177

R06AE07

ATC

cetirizine; oral

1.6

307.7

16986

62379

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

7.6

307.7

2219

1556

XF404

NOMESCO Finland

Ambulatory ECG

3.1

307.7

3347

5761

UJF32

NOMESCO Finland

Coloscopy

2.7

307.7

10501

22960

UJF30

NOMESCO Finland

Ileoscopy through colon

3.3

307.7

4268

7075

J01MA02

ATC

ciprofloxacin; systemic

1.8

307.7

15079

49823

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

16997

58692

A29

ICPC

General symptom/complaint other

2.5

307.7

5536

12343

ZY010

NOMESCO Finland

Hospital outpatient

3.1

307.7

1957

3357

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

307.7

3438

6082

P03

ICPC

Feeling depressed

2.2

307.7

4134

9943

Z97.4

ICD-10 Finland

Presence of external hearing-aid

5.2

307.7

1456

1470

K30

ICD-10 Finland

Functional dyspepsia

2.3

307.7

4233

10144

XQ800

NOMESCO Finland

Prick test

5.1

307.7

2817

2978

H02AB06

ATC

prednisolone; systemic

2.0

307.7

19310

63460

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

307.7

22066

82493

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

307.7

5175

13205

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

307.7

17020

58762

RD211, ,

NOMESCO Finland

4.3

307.7

1218

1491

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

307.7

4316

11272

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

307.7

8764

29045

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

307.7

3899

8782

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.5

307.7

1797

2735

SPAT1254

SPAT

Administration of medicine

2.1

307.7

5536

14401

N02BF01

ATC

gabapentin; oral

2.3

307.7

3616

8472

SPAT1263

SPAT

Sampling

1.6

307.7

15659

56306

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

307.7

5131

13993

N06AX12

ATC

bupropion; oral

2.4

307.7

2899

6325

DFF00

NOMESCO Finland

Pure tone audiometry

4.0

307.7

3326

4556

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

307.7

4133

10020

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

307.7

4977

11260

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.7

307.7

5120

10543

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

307.7

17124

56054

A02BC02

ATC

pantoprazole; systemic

2.3

307.7

28753

101303

N06AB04

ATC

citalopram; systemic

2.1

307.7

7946

21270

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

39.3

307.7

4523

652

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

307.7

9095

23520

R05

ICD-10 Finland

Cough

1.8

307.7

7694

24198

N02AA05

ATC

oxycodone; systemic

2.1

307.7

6610

17602

XQ802

NOMESCO Finland

Epicutan test

6.2

307.7

1252

1059

L17

ICPC

Foot/toe symptom/complaint

1.9

307.7

11847

36203

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

102.8

307.7

2127

111

N03AE01

ATC

clonazepam; systemic

3.1

307.7

2104

3631

R60.0

ICD-10 Finland

Localized oedema

2.1

307.7

4406

11392

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

10922

30065

P29

ICPC

Psychological sympt/compl other

2.5

307.7

3145

6607

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

307.7

9468

25806

SPAT1301

SPAT

No procedures

1.7

307.7

10951

37472

L12

ICPC

Hand/finger symptom/complaint

1.8

307.7

6356

19096

Z00.8

ICD-10 Finland

Other general examinations

3.3

307.7

2902

4690

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

307.7

6914

18833

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

307.7

8672

24972

M79.1

ICD-10 Finland

Myalgia

2.1

307.7

5719

15039

L28

ICPC

Limited function/disability (L)

2.4

307.7

7305

17002

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

307.7

20456

82487

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

10.1

307.7

638

328

N02BE01

ATC

paracetamol; systemic, rectal

2.5

307.7

38139

160193

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

14989

47128

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

307.7

4419

11563

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

307.7

19788

59230

J01AA02

ATC

doxycycline; systemic

1.7

307.7

30801

129332

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

307.7

3574

7743

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.2

307.7

3614

6193

-1, ,

NOMESCO Finland

1.7

307.7

12694

43078

XF402

NOMESCO Finland

ECG with work load test

3.2

307.7

4116

6965

C07AB07

ATC

bisoprolol; oral

1.9

307.7

18508

61616

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

307.7

7485

22662

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

307.7

11860

35582

Z00.0

ICD-10 Finland

General medical examination

3.3

307.7

7413

13147

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

8303

25227

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

307.7

12756

25222

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

307.7

20812

80789

R29

ICPC

Respiratory symptom/complaint other

2.6

307.7

2648

5417

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

307.7

29806

121205

R03DC03

ATC

montelukast; oral

2.0

307.7

6032

16761

Z01.8

ICD-10 Finland

Other specified special examinations

8.9

307.7

9533

6757

A10AB05

ATC

insulin aspart; parenteral

2.7

307.7

2775

5417

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.5

307.7

2247

3423

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

307.7

3953

6779

N06AA09

ATC

amitriptyline; systemic

2.5

307.7

3128

6645

K02.1

ICD-10 Finland

Caries of dentine

1.6

307.7

23994

96541

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

35.9

307.7

521

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

307.7

2732

5717

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

307.7

1989

3665

XCK00

NOMESCO Finland

Perimetry

3.5

307.7

2069

3085

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

13156

43040

KMAK, ,

NOMESCO Finland

1.6

307.7

19453

75304

A10AE04

ATC

insulin glargine; parenteral

2.4

307.7

3417

7500

SFA10

NOMESCO Finland

One-surface restoration

1.6

307.7

21895

86051

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

307.7

3447

8162

S06.0

ICD-10 Finland

Concussion

2.2

307.7

4178

10402

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

307.7

9833

29235

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

9560

29962

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

307.7

5574

15908

R11

ICD-10 Finland

Nausea and vomiting

2.5

307.7

3499

7439

ZX120

NOMESCO Finland

Intravenous

2.6

307.7

3323

6838

R05

ICPC

Cough

1.8

307.7

9291

29079

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

5.0

307.7

985

1024

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

10028

32626

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.6

307.7

2673

5502

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

13.4

307.7

1717

680

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

307.7

3358

5756

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.9

307.7

2227

2411

R13

ICD-10 Finland

Dysphagia

2.7

307.7

2431

4815

E0000UV, ,

ATC

1.7

307.7

16168

58158

N17

ICPC

Vertigo/dizziness

2.1

307.7

4445

11646

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

5131

12264

Z50.1

ICD-10 Finland

Other physical therapy

3.8

307.7

2150

3036

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

307.7

4453

9818

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

307.7

3267

7653

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.4

307.7

1124

1327

R00.2

ICD-10 Finland

Palpitations

2.5

307.7

3057

6611

J01FA10

ATC

azithromycin; systemic

1.5

307.7

22333

91095

R52.2

ICD-10 Finland

Other chronic pain

4.0

307.7

1454

1904

Z3231

NOMESCO Finland

Registered nurse

2.0

307.7

10254

29443

N03AG01

ATC

valproic acid; systemic, rectal

3.1

307.7

2402

4159

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

54.9

307.7

1746

169

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

307.7

3330

7321

S29

ICPC

Skin symptom/complaint other

1.9

307.7

7568

22551

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.6

307.7

3259

6700

SFA20

NOMESCO Finland

Two-surface restoration

1.5

307.7

22780

93302

L03

ICPC

Low back symptom/complaint

2.0

307.7

11778

34834

N06AB10

ATC

escitalopram; oral

2.0

307.7

8361

23295

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

307.7

4564

11891

XA420

NOMESCO Finland

Extensive sleep examination

11.8

307.7

562

247

R50.9

ICD-10 Finland

Fever, unspecified

2.1

307.7

6107

16043

R07.3

ICD-10 Finland

Other chest pain

2.4

307.7

3879

8822

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

307.7

27147

113079

XCK10

NOMESCO Finland

Photography of fundus of eye

2.9

307.7

2862

5282

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

17.8

307.7

13221

5266

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

18917

74758

N05AH03

ATC

olanzapine; systemic

3.0

307.7

2660

4687

T90

ICPC

Diabetes non-insulin dependent

1.8

307.7

8203

25645

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.7

307.7

900

815

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

307.7

6103

16847

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

17757

58266

N06AX21

ATC

duloxetine; oral

2.9

307.7

4900

9307

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

11073

38556

C03CA01

ATC

furosemide; systemic

1.8

307.7

10933

34298

R55

ICD-10 Finland

Syncope and collapse

2.1

307.7

4024

10355

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.5

307.7

2406

3683

XG410

NOMESCO Finland

Flow-volume spirometry

5.3

307.7

1624

1599

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

307.7

8973

28169

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

12.6

307.7

536

220

DFF15

NOMESCO Finland

Speech audiometry

5.1

307.7

1375

1409

C07AA05

ATC

propranolol; systemic

2.0

307.7

7647

21640

N05BA01

ATC

diazepam; systemic, rectal

2.1

307.7

4628

11973

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.5

307.7

1518

2285

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

307.7

7769

21971

N06AX16

ATC

venlafaxine; oral

2.6

307.7

5865

12637

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

307.7

18112

66680

Z01.1

ICD-10 Finland

Examination of ears and hearing

8.2

307.7

5323

3692

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

307.7

5376

12514

A02BC05

ATC

esomeprazole; systemic

2.0

307.7

15839

50169

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.2

307.7

2715

4532

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

9276

23623

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.8

307.7

1822

2545

L15

ICPC

Knee symptom/complaint

1.7

307.7

8919

29200

P76

ICPC

Depressive disorder

2.5

307.7

2654

5561

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

7063

17895

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

307.7

11692

29668

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

307.7

7445

21023

UKC02

NOMESCO Finland

Cystoscopy

2.2

307.7

5940

14723

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

22237

88430

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

307.7

9347

29309

L01

ICPC

Neck symptom/complaint

2.0

307.7

6082

16761

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

70.4

307.7

6499

551

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.2

307.7

1346

1670

D01

ICPC

Abdominal pain/cramps general

2.2

307.7

4837

12129

H02AB04

ATC

methylprednisolone; systemic

2.1

307.7

5245

13684

J01DB01

ATC

cefalexin; oral

2.2

307.7

35416

145685

M01AH05

ATC

etoricoxib; oral

1.5

307.7

23699

97395

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.7

11953

38389

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

307.7

7411

18561

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.4

307.7

2263

2251

M03BX02

ATC

tizanidine; oral

1.6

307.7

23893

96139

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

17518

55093

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

307.7

4841

12486

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

32.5

307.7

20545

5850

AA1AD

NOMESCO Finland

CT of head and brain

2.2

307.7

11307

30545

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

307.7

21656

87284

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

307.7

11626

37293

S18

ICPC

Laceration/cut

2.0

307.7

18717

61164

M25.5

ICD-10 Finland

Pain in joint

1.9

307.7

13186

40548

J01MA12

ATC

levofloxacin; systemic

2.0

307.7

7044

19432

SPAT1216

SPAT

Assessment of functional ability

2.5

307.7

5387

12009

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

14614

51302

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

111.3

307.7

1373

A02BC03

ATC

lansoprazole; oral

1.8

307.7

9840

31146

G44.2

ICD-10 Finland

Tension-type headache

2.1

307.7

5021

12756

P01

ICPC

Feeling anxious/nervous/tense

2.0

307.7

5363

14286

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

307.7

5976

15862

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

307.7

7848

24665

N06AX11

ATC

mirtazapine; oral

2.1

307.7

14020

40981

Z01.0

ICD-10 Finland

Examination of eyes and vision

15.5

307.7

6553

2502

A28

ICPC

Limited function/disability NOS

2.0

307.7

6062

16315

A01

ICPC

Pain general/multiple sites

2.6

307.7

3946

8124

N05BA04

ATC

oxazepam; oral

2.1

307.7

10687

29414

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

307.7

9318

27801

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

307.7

3271

7154

N06AB06

ATC

sertraline; oral

2.3

307.7

4448

10574

Z04.3

ICD-10 Finland

Examination and observation following other accident

65.0

307.7

787

B01AC04

ATC

clopidogrel; oral

1.9

307.7

5239

14808

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

11227

28286

J01EA01

ATC

trimethoprim; systemic

1.7

307.7

8814

28761

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

14.0

307.7

6102

2551

A04

ICPC

Weakness/tiredness general

2.4

307.7

6810

15911

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

307.7

4060

9822

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.6

307.7

2216

3226

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

307.7

9355

30489

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.7

8744

25920

J02AC01

ATC

fluconazole; systemic

1.6

307.7

13704

48400

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

46.0

307.7

953

108

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

307.7

10337

35242

XA402

NOMESCO Finland

ENMG

14.5

307.7

1224

442

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

307.7

5789

11587

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

307.7

14256

48829

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

307.7

6995

18137

EBA00

NOMESCO Finland

Extraction of tooth

1.5

307.7

14160

52790

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

307.7

5857

16795

X58

ICD-10 Finland

Exposure to other specified factors

1.9

307.7

5749

16708

B01AB05

ATC

enoxaparin; parenteral

1.8

307.7

10976

35805

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

307.7

15444

53302

SPAT1229

SPAT

Assessment of need for aid

2.5

306.8

2394

5029

N06AB03

ATC

fluoxetine; oral

2.0

306.3

4097

10864

A02BA02

ATC

ranitidine; systemic

1.8

305.6

6245

19087

UJF92

NOMESCO Finland

Capsular endoscopy

5.3

305.1

820

798

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.3

304.2

2962

6904

L16

ICPC

Ankle symptom/complaint

2.0

302.6

4383

11962

C10AA01

ATC

simvastatin; oral

1.5

302.4

13299

49464

R01AD08

ATC

fluticasone; nasal

1.6

301.0

10227

35834

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

300.2

7869

25807

P20

ICPC

Memory disturbance

2.0

300.1

4213

11367

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

300.0

3595

9136

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

299.6

3628

9257

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

299.0

3113

7468

A98

ICPC

Health maint/preventive medicine

2.0

295.8

41176

195896

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

295.1

2491

5435

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

295.0

10598

37603

R74

ICPC

Upper respiratory infection acute

1.5

294.8

12888

47812

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

294.5

2759

6318

CS494

NOMESCO Finland

Other visual field testing

5.0

294.0

842

874

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

293.8

6937

22090

L29

ICPC

Musculoskeletal sympt/complt other

2.2

293.8

3166

7704

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.0

293.1

4166

11285

SPAT1240

SPAT

Therapeutic discussion

2.1

292.6

3740

9740

M01AB05

ATC

diclofenac; systemic, rectal

1.5

292.3

25147

106933

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

291.9

8190

27323

R03BA05

ATC

fluticasone; inhalant

1.7

291.7

6499

20351

R21

ICPC

Throat symptom/complaint

1.6

290.7

8255

27621

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.1

290.3

3693

9599

N05AX08

ATC

risperidone; systemic

2.2

290.1

3223

7941

L13

ICPC

Hip symptom/complaint

1.8

290.0

6160

19020

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

289.8

3729

9735

N05CF02

ATC

zolpidem; oral

1.8

289.4

5838

17748

A06AD11

ATC

lactulose; oral

1.9

288.6

5047

14671

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.6

288.5

2130

4347

N05BA12

ATC

alprazolam; oral

2.1

287.2

3336

8367

D07AC01

ATC

betamethasone; topical

1.5

287.2

13094

48961

AN1

Coronary angiography

2.1

287.0

3379

8521

A10AB04

ATC

insulin lispro; parenteral

4.0

285.9

1067

1403

Z03.0

ICD-10 Finland

Observation for suspected tuberculosis

72.5

284.8

282

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.8

283.2

5214

15403

SPAT1153

SPAT

Removal of sutures

1.6

283.1

9968

35141

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.1

282.0

788

798

ZXD05

NOMESCO Finland

Urgent procedure

1.6

280.9

11015

39800

A10BA02

ATC

metformin; oral

1.6

280.7

9583

33528

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

280.5

2336

5061

T78.4

ICD-10 Finland

Allergy, unspecified

2.9

280.2

1643

2951

C01CA24

ATC

epinephrine; parenteral

2.5

280.1

2183

4578

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

278.4

2439

5412

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

276.4

4045

11061

R35

ICD-10 Finland

Polyuria

2.4

275.4

2362

5189

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

275.3

3419

8798

A10AE05

ATC

insulin detemir; parenteral

2.8

275.1

1757

3315

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

274.7

8343

28345

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

274.1

8028

27024

XG405

NOMESCO Finland

Education on PEF monitoring

7.8

273.4

536

354

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.6

272.9

1140

1635

SPAT1097

SPAT

Recording of ECG

1.9

272.6

4371

12333

XKD00

NOMESCO Finland

Uroflowmetry

1.8

270.4

5172

15445

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

269.7

6992

22789

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

269.6

3681

9812

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

269.6

2243

4855

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

269.6

13676

52139

M01AC06

ATC

meloxicam; systemic, rectal

1.5

269.4

11981

44430

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

267.7

3921

10718

M54.2

ICD-10 Finland

Cervicalgia

2.2

267.5

2811

6759

A02BC01

ATC

omeprazole; systemic

1.6

266.5

9323

32745

SPAT1360

SPAT

Extensive global examination

2.4

264.1

2274

5002

H25.8

ICD-10 Finland

Other senile cataract

2.0

264.1

3375

8775

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

263.4

4457

12794

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

262.8

2742

6572

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

262.8

6606

21337

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.6

262.7

1948

3981

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

262.0

2568

5991

SPAT1252

SPAT

Overall medication plan or its review

2.6

261.7

1908

3865

R03BA02

ATC

budesonide; inhalant

1.7

261.6

6309

20145

C08CA01

ATC

amlodipine; oral

1.5

261.5

12697

47901

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

261.3

6117

19371

A11

ICPC

Chest pain NOS

2.2

260.0

2816

6855

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

259.8

8159

27900

J01FA06

ATC

roxithromycin; oral

1.5

259.6

13882

53396

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.5

259.5

1152

1726

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

259.0

2730

6570

SPAT1234

SPAT

Support of social functional capacity

2.7

258.4

1749

3406

G04BD12

ATC

mirabegron; oral

2.0

258.1

3642

9819

SFA30

NOMESCO Finland

Three-surface restoration

1.5

257.9

15170

59439

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

257.7

7491

25120

F34.1

ICD-10 Finland

Dysthymia

3.2

256.6

1311

2161

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

256.4

3969

11053

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

255.9

2362

5364

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

255.7

2937

7321

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

255.6

1927

3971

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

255.4

4745

14026

-69

ICPC

Other reason for encounter NEC

3.1

254.1

1359

2306

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.8

254.1

999

1368

A46

ICD-10 Finland

Erysipelas

1.8

254.0

5054

15255

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

253.8

2607

6204

127

Kela drug reimbursment

Transplant complication

6.0

253.8

607

519

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.9

252.2

971

1308

A02BC04

ATC

rabeprazole; oral

2.1

252.1

2876

7148

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.9

251.9

1512

2751

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.8

251.6

985

1344

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

251.6

3170

8191

M01AH01

ATC

celecoxib; oral

1.7

250.8

5723

17976

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

250.7

2533

5985

K29

ICPC

Cardiovascular sympt/complt other

2.9

250.1

1482

2676

H02AB09

ATC

hydrocortisone; systemic

4.1

249.7

883

1110

WX002

NOMESCO Finland

Sedation and analgesia

1.7

249.6

6071

19409

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

249.2

3401

9053

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

249.0

7927

27162

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.8

248.5

1519

2793

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

248.1

1449

2594

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.3

248.1

837

1011

R03BA08

ATC

ciclesonide; inhalant

2.1

247.5

2848

7101

Z01.9

ICD-10 Finland

Special examination, unspecified

2.6

247.2

1836

3753

XG474

NOMESCO Finland

Exhalation nntrogen oxide

4.3

247.1

835

1010

N06BA04

ATC

methylphenidate; oral

3.0

246.7

1380

2407

R03BB04

ATC

tiotropium bromide; inhalant

2.0

246.3

3299

8720

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

244.9

4530

13361

R06AX22

ATC

ebastine; oral

1.7

244.4

5890

18773

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

244.2

2520

6006

J01MA14

ATC

moxifloxacin; systemic

2.1

243.5

2983

7622

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

243.2

2455

5796

D02

ICPC

Abdominal pain epigastric

2.4

243.0

2146

4773

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

242.5

2633

6410

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

242.5

1984

4256

A05

ICPC

Feeling ill

2.3

242.0

2357

5479

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

241.9

3355

8980

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

241.7

14618

57392

R5120

NOMESCO Finland

Preparation of an aid

4.3

241.3

806

965

L04AA06

ATC

mycophenolic acid; systemic

4.8

241.2

721

780

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.0

240.9

885

1148

A10AE06

ATC

insulin degludec; parenteral

3.2

240.8

1207

1964

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.3

239.9

555

456

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

5.5

239.2

625

590

SPAT1359

SPAT

Use of symptom diary

4.4

238.0

773

903

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

237.8

2084

4618

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

237.5

7589

25990

C09CA06

ATC

candesartan; oral

1.6

237.4

8337

29197

H29

ICPC

Ear symptom/complaint other

1.9

236.7

4015

11512

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.2

236.6

811

993

L14

ICPC

Leg/thigh symptom/complaint

2.1

236.5

2806

7078

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.1

235.8

842

1067

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

235.2

2897

7415

K03.66

ICD-10 Finland

Tooth plaque

2.1

235.1

2755

6915

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

234.6

9403

33911

J01FA09

ATC

clarithromycin; systemic

1.5

234.6

10959

40830

EB1VA, ,

NOMESCO Finland

1.6

233.7

6367

20945

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

233.6

3146

8326

H02AB07

ATC

prednisone; oral

1.8

233.2

4541

13595

S97

ICPC

Chronic ulcer skin

2.4

233.0

2046

4537

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

232.2

3678

10305

J05AB01

ATC

aciclovir; systemic

1.6

231.1

7353

25136

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

230.8

2027

4495

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

230.8

9354

33799

R83

ICPC

Respiratory infection other

1.5

230.7

9784

35699

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

230.4

2095

4720

H13

ICPC

Plugged feeling ear

1.6

230.3

6259

20570

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

230.0

1715

3511

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

229.9

12831

49490

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

229.7

7257

24762

M01AX17

ATC

nimesulide; oral

1.6

229.4

7403

25390

D06

ICPC

Abdominal pain localized other

2.0

229.2

3071

8111

P99

ICPC

Psychological disorders other

3.2

228.1

1147

1870

H04AA01

ATC

glucagon; nasal, parenteral

4.1

227.9

805

1011

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.9

227.8

1335

2394

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

227.6

1658

3354

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

226.9

3124

8331

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

226.7

2073

4682

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

226.1

2056

4632

E66.8

ICD-10 Finland

Other obesity

2.4

225.6

1918

4188

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

225.5

2587

6436

Z2445

NOMESCO Finland

Psychologist

2.9

225.0

1306

2328

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

224.6

4741

14528

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

223.8

6417

21364

E000001, ,

ATC

1.6

223.4

6858

23220

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

223.0

4088

12003

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.6

222.8

1623

3282

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

222.7

2137

4931

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

222.3

2118

4872

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

221.8

6785

22949

A10AB01

ATC

insulin (human); parenteral

3.1

220.9

1135

1876

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

220.9

2811

7279

H01

ICPC

Ear pain/earache

1.8

220.8

4160

12317

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

220.5

4428

13366

G04CA02

ATC

tamsulosin; oral

1.5

220.4

8008

28201

R01AD58

ATC

fluticasone, combinations; nasal

1.5

220.1

8941

32272

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

219.7

12637

48930

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

218.8

4659

14305

K22

ICPC

Risk factor cardiovascular disease

2.4

218.5

1813

3912

P74

ICPC

Anxiety disorder/anxiety state

2.5

217.7

1708

3586

N04BC05

ATC

pramipexole; oral

2.2

217.4

2296

5519

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.7

217.2

1447

2790

J45.8

ICD-10 Finland

Mixed asthma

3.3

216.8

1023

1598

N06AX22

ATC

agomelatine; oral

3.7

216.5

866

1201

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

16.9

216.1

286

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

215.8

4070

12050

L02

ICPC

Back symptom/complaint

1.9

215.7

3664

10494

Y96.9

ICD-10 Finland

Unspecified type of accident

4.3

215.3

717

856

L04AX01

ATC

azathioprine; systemic

2.7

215.2

1446

2801

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.2

214.8

2163

5095

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

214.8

9483

34811

R31

ICD-10 Finland

Unspecified haematuria

1.9

214.7

3428

9620

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

214.3

1352

2529

R01AD12

ATC

fluticasone furoate; nasal

1.5

214.2

11304

43008

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

213.6

7202

24909

JN4AD

NOMESCO Finland

Body CT examination

1.8

213.4

3658

10507

XCW10

NOMESCO Finland

Assessment of vision

5.9

213.1

519

453

S21

ICPC

Skin texture symptom/complaint

1.7

213.1

5142

16346

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

212.8

2418

5988

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

212.4

1763

3804

R4110, ,

SPAT

1.8

212.3

4049

12026

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

211.8

2681

6925

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.0

211.6

1147

1961

SPAT1211

SPAT

Application of soft bandage

2.0

211.4

2883

7655

SPAT1104

SPAT

Monitoring of emergency patient

2.3

211.1

2074

4833

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

211.0

10180

38029

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.8

210.0

1331

2496

B01AA03

ATC

warfarin; systemic

1.6

210.0

6059

20174

Z2446

NOMESCO Finland

Social worker

2.2

209.8

2163

5146

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.8

209.1

1283

2362

DAX08

NOMESCO Finland

Fitting of hearing aid

2.6

208.5

1485

2967

R06AX27

ATC

desloratadine; oral

1.5

208.5

10180

38106

R5110, ,

SPAT

2.1

208.2

2472

6228

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

207.9

9932

37011

A10AC01

ATC

insulin (human); parenteral

2.1

207.3

2449

6158

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.1

207.2

2357

5838

SPAT1172

SPAT

Guidance concerning hydration

3.7

207.1

831

1155

SPAT1262

SPAT

Handing over of treatment supplies

1.7

207.1

5424

17613

A10BH01

ATC

sitagliptin; oral

2.0

207.0

2817

7472

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

206.7

1381

2666

C10AX09

ATC

ezetimibe; oral

1.7

206.6

5196

16692

C09AA05

ATC

ramipril; oral

1.5

206.2

7951

28319

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

206.2

3430

9751

R06AE09

ATC

levocetirizine; oral

1.7

205.7

4857

15337

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

13.7

204.9

294

110

C03DA01

ATC

spironolactone; oral

1.8

203.6

3966

11847

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

203.2

26536

117654

GX2C5

NOMESCO Finland

Short-lasting oximetry

14.1

202.9

288

105

F61.0

ICD-10 Finland

Mixed personality disorders

4.7

202.6

623

692

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

202.0

2552

6583

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.0

201.8

1114

1926

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

201.2

2316

5762

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

200.7

3371

9610

A99

ICPC

Disease/condition unspecnature/site

1.8

200.5

3524

10194

A06AC51

ATC

ispaghula, combinations; oral

2.5

200.3

1524

3149

D07AD01

ATC

clobetasol; topical

1.6

199.9

5436

17810

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

199.2

2312

5771

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

199.0

3081

8548

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.2

198.9

1005

1643

K07.60

ICD-10 Finland

Snapping jaw

2.4

198.8

1705

3735

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.3

198.4

1786

4001

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

198.1

9489

35325

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

198.0

1627

3492

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.3

197.9

665

800

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

197.9

1802

4058

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

196.7

2555

6658

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.7

196.0

784

1087

XA800

NOMESCO Finland

Neuropsychological investigation

2.6

195.5

1368

2707

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.5

194.7

618

707

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

194.6

12280

48131

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

194.4

1035

1749

C10AA07

ATC

rosuvastatin; oral

1.4

193.6

10799

41370

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.2

193.2

662

810

ZXA00

NOMESCO Finland

Right side

1.5

192.9

8038

29057

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

192.9

4493

14119

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.2

192.4

983

1618

GD1AA, ,

SPAT

1.6

191.9

5947

20110

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

4.2

190.7

662

819

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

190.4

1985

4741

SDA03

NOMESCO Finland

Periodontal treatment

1.4

190.2

14817

60175

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

189.7

1062

1851

N05BE01

ATC

buspirone; oral

3.1

188.3

997

1679

J01CA08

ATC

pivmecillinam; oral

1.4

188.1

12960

51520

R01AD11

ATC

triamcinolone; nasal

1.9

187.8

2720

7370

C07AB02

ATC

metoprolol; systemic

1.6

187.2

6354

21939

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.6

187.2

480

444

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

186.3

4696

15065

WX320

NOMESCO Finland

Spinalanesthesy

1.5

185.8

8031

29224

C01DA14

ATC

isosorbide mononitrate; oral

1.6

185.6

4888

15861

R03AC03

ATC

terbutaline; inhalant

1.7

185.0

4528

14412

A08

ICPC

Swelling

2.3

184.7

1752

4016

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

183.5

1949

4689

P06

ICPC

Sleep disturbance

1.7

183.4

4409

13963

H02

ICPC

Hearing complaint

1.7

182.9

4209

13170

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

182.7

9825

37309

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.1

182.1

2120

5294

J01DA09

ATC

[U] cefadroxil

1.5

181.9

9198

34515

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

181.6

1598

3540

F29

ICPC

Eye symptom/complaint other

1.8

181.6

3502

10412

N05AN01

ATC

lithium; oral

3.4

180.2

827

1267

K08.80

ICD-10 Finland

Toothache NOS

1.8

180.1

3099

8892

N03AX11

ATC

topiramate; oral

3.4

180.0

817

1242

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

180.0

3097

8886

FN1AD

NOMESCO Finland

CT of coronary arteries

4.0

179.8

650

832

WX722

NOMESCO Finland

PEEP

2.4

179.2

1458

3112

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

178.8

9850

37547

WZC30

NOMESCO Finland

Teaching

1.6

178.6

5010

16509

K80

ICPC

Cardiac arrhythmia NOS

1.9

178.1

2635

7188

R06.5

ICD-10 Finland

Mouth breathing

1.9

177.9

2966

8422

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

177.9

8977

33651

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

177.6

1093

2014

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.1

177.5

914

1512

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.7

177.3

543

601

H3600, E103,

ICD-10 Finland

7.2

176.3

366

262

U07

ICPC

Urine symptom/complaint other

1.9

175.9

2682

7392

U01

ICPC

Dysuria/painful urination

2.0

175.7

2468

6610

B01AF02

ATC

apixaban; oral

1.7

174.8

3926

12194

M02AA10

ATC

ketoprofen; topical

1.6

174.7

5015

16614

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

174.6

3525

10618

M04AA01

ATC

allopurinol; systemic

1.7

174.3

4158

13129

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

174.2

2394

6361

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

11.0

174.2

277

129

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

174.0

2220

5740

A07AA02

ATC

nystatin; oral

2.3

173.7

1684

3896

F41.00

ICD-10 Finland

Moderate panic disorder

4.3

172.6

577

691

J37.0

ICD-10 Finland

Chronic laryngitis

2.9

172.5

1033

1874

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

3.0

172.5

938

1606

N05AA02

ATC

levomepromazine; systemic

2.5

172.2

1346

2817

N06AB05

ATC

paroxetine; oral

2.2

172.1

1871

4543

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.1

171.7

2036

5118

N07BB01

ATC

disulfiram; oral

2.4

171.6

1490

3280

L04

ICPC

Chest symptom/complaint

2.1

171.2

2063

5219

D19

ICPC

Teeth/gum symptom/complaint

1.4

170.9

11076

43410

IHA11, ,

SPAT

4.5

170.7

546

629

K59.0

ICD-10 Finland

Constipation

2.1

170.4

1868

4551

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

170.1

2035

5133

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.6

169.9

1242

2513

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

169.4

1754

4173

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.1

169.1

863

1419

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

169.1

12146

48430

C08CA13

ATC

lercanidipine; oral

1.7

169.0

4251

13608

M02AA07

ATC

piroxicam; topical

1.4

168.3

11452

45239

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

168.0

36681

173770

R12

ICD-10 Finland

Heartburn

1.9

168.0

2774

7848

Z94.0

ICD-10 Finland

Kidney transplant status

5.9

167.9

410

359

L04AD02

ATC

tacrolimus; systemic

6.1

167.8

398

337

A10BK01

ATC

dapagliflozin; oral

1.9

167.4

2424

6559

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.0

167.4

930

1613

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

167.1

1193

2384

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.4

167.1

1416

3081

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.4

167.1

1377

2957

D07AC13

ATC

mometasone; topical

1.4

167.0

9631

36947

UJD02

NOMESCO Finland

Gastroscopy

2.4

166.9

1397

3022

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

32.5

166.2

184

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.7

165.9

675

948

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

165.8

13471

54770

ZXA05

NOMESCO Finland

Left side

1.5

165.6

7350

26812

Z3226

NOMESCO Finland

Physiotherapist

1.6

165.3

5577

19180

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.3

165.2

1493

3347

Z29

ICPC

Social problem NOS

3.3

165.1

772

1198

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

165.1

18825

80602

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

165.0

4218

13555

C10AC01

ATC

colestyramine; oral

3.1

164.9

867

1453

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

164.7

1960

4933

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

164.4

1774

4293

SPAT1260

SPAT

Consultation of another employee

1.6

164.1

5451

18677

U29

ICPC

Urinary symptom/complaint other

2.9

163.8

984

1788

SFA00

NOMESCO Finland

Small restoration

1.6

163.3

4550

14945

J45

ICD-10 Finland

Asthma

1.7

163.2

3423

10418

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

162.7

1645

3874

G04BD08

ATC

solifenacin; oral

2.1

162.6

1827

4494

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.8

161.9

632

860

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

9.2

161.5

285

160

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.0

161.0

905

1581

R33

ICD-10 Finland

Retention of urine

1.9

160.9

2556

7136

Z08

ICPC

Social welfare problem

4.8

160.8

476

510

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

160.6

732

1116

XG466

NOMESCO Finland

Sleep oxymetry

2.9

160.5

925

1640

N27

ICPC

Fear of neurological disease other

4.2

160.3

554

683

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

160.2

1375

3009

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.9

160.2

599

788

PA6AD

NOMESCO Finland

CT of neck arteries

2.6

160.0

1174

2379

S04

ICPC

Lump/swelling localized

1.7

160.0

3668

11444

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

159.5

2233

5968

N06AX05

ATC

trazodone; oral

3.2

159.3

784

1259

D82

ICPC

Teeth/gum disease

1.4

159.1

14095

57997

S76

ICPC

Skin infection other

2.2

159.1

1729

4196

M01AH02

ATC

rofecoxib; oral

1.7

159.0

3634

11327

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.6

158.6

403

369

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

158.6

1807

4469

SPAT1312

SPAT

General health counselling

1.4

158.2

10745

42347

K07

ICPC

Swollen ankles/oedema

2.4

157.7

1378

3041

H53.2

ICD-10 Finland

Diplopia

2.8

157.6

993

1854

N03AF02

ATC

oxcarbazepine; oral

2.7

157.5

1078

2106

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

157.4

1338

2915

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

5.5

157.3

410

386

B01AF01

ATC

rivaroxaban; oral

1.7

157.0

3612

11277

K04

ICPC

Palpitations/awareness of heart

2.2

156.9

1647

3939

IHA10, ,

SPAT

2.9

156.8

916

1637

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

156.5

1203

2496

RF410, ,

NOMESCO Finland

6.7

156.5

342

262

U05

ICPC

Urination problems other

2.2

156.5

1594

3765

A10AA01, ,

ATC

3.2

156.2

770

1238

207

Kela drug reimbursment

Chronic arrhythmias

1.6

156.1

4555

15121

M54.8

ICD-10 Finland

Other dorsalgia

2.2

156.1

1521

3524

L11

ICPC

Wrist symptom/complaint

1.8

155.9

2994

8874

L86

ICPC

Back syndrome with radiating pain

2.0

155.8

1929

4927

SPAT1255

SPAT

Intravenous administration of medicine

2.0

155.4

1995

5166

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.2

154.9

1505

3483

R07.0

ICD-10 Finland

Pain in throat

1.9

154.8

2531

7131

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.0

154.5

2067

5434

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

154.4

3985

12825

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

154.4

1745

4301

Z11

ICPC

Compliance/being ill problem

8.5

154.4

285

172

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

154.2

2154

5751

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

154.2

988

1862

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.0

154.1

327

241

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.5

153.9

495

573

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

153.8

1542

3617

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

153.4

3112

9373

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.3

153.2

1462

3357

P25

ICPC

Phase of life problem adult

2.3

153.0

1479

3415

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

152.5

864

1516

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.8

152.4

920

1676

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

152.2

1729

4270

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

152.1

2829

8302

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

151.9

2834

8324

WX892

NOMESCO Finland

Monitored bed care

1.9

151.8

2339

6460

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.2

151.7

1580

3766

R4110

NOMESCO Finland

Physiotherapy

1.4

151.6

9030

34747

M35.7

ICD-10 Finland

Hypermobility syndrome

4.4

151.3

487

564

ACC51

NOMESCO Finland

Release of median nerve

1.9

151.3

2223

6041

M54.1

ICD-10 Finland

Radiculopathy

2.4

150.4

1258

2719

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

150.4

762

1247

H57.1

ICD-10 Finland

Ocular pain

2.4

150.4

1272

2764

S10

ICPC

Boil/carbuncle

2.0

150.1

1952

5078

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

150.0

1283

2803

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

3.5

149.8

646

947

R51

ICD-10 Finland

Headache

2.0

149.6

1957

5102

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

149.4

7773

29171

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

149.2

10286

40567

L04AX03

ATC

methotrexate; systemic

1.8

149.0

2948

8811

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.6

148.5

377

345

N06AX03

ATC

mianserin; oral

2.3

148.5

1387

3154

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.3

148.2

718

1141

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

148.2

6895

25326

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

147.9

3392

10572

SGA01

NOMESCO Finland

Emergency treatment

1.5

147.7

5733

20292

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.1

147.6

756

1246

-50

ICPC

Medication/prescr/renewal

2.5

146.8

1170

2471

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

146.3

3331

10361

L05

ICPC

Flank/axilla symptom/complaint

2.0

146.2

2011

5338

N03AF01

ATC

carbamazepine; oral, rectal

2.2

146.0

1538

3683

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

145.9

2293

6373

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

145.3

1051

2114

M05BA04

ATC

alendronic acid; oral

1.9

144.7

2280

6343

TK800

NOMESCO Finland

Hemodialysis

3.3

144.4

688

1081

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

144.1

1629

4014

S80.0

ICD-10 Finland

Contusion of knee

1.8

144.0

2527

7278

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.5

143.2

455

521

R03BA01

ATC

beclometasone; inhalant

1.6

142.9

4242

14123

-34

ICPC

Blood test

2.8

142.7

867

1585

N05CD07

ATC

temazepam; oral

1.7

142.7

3557

11332

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

142.6

2626

7677

R30.0

ICD-10 Finland

Dysuria

2.2

142.6

1440

3387

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.2

142.4

1482

3530

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.9

142.3

811

1428

ZYC05, ,

SPAT

2.3

142.3

1309

2956

K92.1

ICD-10 Finland

Melaena

2.1

141.9

1671

4184

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

141.3

1593

3921

U04

ICPC

Incontinence urine

2.1

141.2

1593

3922

J30.3

ICD-10 Finland

Other allergic rhinitis

2.4

140.9

1149

2453

N05AF03

ATC

chlorprothixene; systemic

2.8

140.9

849

1545

G04CA01

ATC

alfuzosin; oral

1.6

140.9

3897

12749

R06.4

ICD-10 Finland

Hyperventilation

3.9

140.6

534

711

W19

ICD-10 Finland

Unspecified fall

1.7

140.6

3237

10095

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.4

140.4

285

198

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

140.3

2928

8882

P01BA02

ATC

hydroxychloroquine; oral

1.8

139.9

2351

6677

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

139.4

1147

2459

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

139.3

966

1900

Z51.6

ICD-10 Finland

Desensitization to allergens

4.3

139.3

467

561

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

139.3

6529

23985

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.7

138.8

561

784

C09CA01

ATC

losartan; oral

1.4

138.7

7846

29847

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.3

138.6

651

1013

SPAT1167

SPAT

Insertion of urinary catheter

2.7

138.6

946

1845

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.1

138.4

291

212

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

138.3

707

1164

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.1

138.2

1617

4038

D12

ICPC

Constipation

2.4

138.0

1140

2449

N29

ICPC

Neurological sympt/complt other

3.3

137.0

638

987

J05AB11

ATC

valaciclovir; oral

1.6

136.9

4493

15305

TQW80

NOMESCO Finland

Local dermatologic skincare

3.1

136.7

731

1238

C05AA08

ATC

fluocortolone; rectal, topical

1.6

136.7

4030

13386

A10BK03

ATC

empagliflozin; oral

1.7

136.5

2936

8981

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

3.8

136.4

538

738

A11CC03

ATC

alfacalcidol; systemic

3.0

136.4

735

1251

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.5

136.3

601

895

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

136.1

1076

2263

U71

ICPC

Cystitis/urinary infection other

1.9

135.9

1999

5430

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

135.6

3261

10285

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

135.6

1163

2543

N28

ICPC

Limited function/disability (N)

3.6

135.5

565

808

M54.3

ICD-10 Finland

Sciatica

2.0

135.4

1788

4674

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

135.2

2693

8057

XF640, ,

NOMESCO Finland

2.8

135.1

844

1568

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

134.9

2285

6504

D09

ICPC

Nausea

2.1

134.9

1592

3989

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

134.5

772

1365

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

134.4

2171

6086

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.4

134.1

1139

2479

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.4

133.9

1116

2407

SPAT1053

SPAT

Memory test

1.6

133.8

3591

11652

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.9

133.6

772

1371

J46

ICD-10 Finland

Status asthmaticus

2.8

133.4

848

1591

T74.1

ICD-10 Finland

Physical abuse

3.2

133.1

667

1084

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

133.0

8434

32694

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.4

132.9

437

516

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

132.9

1344

3162

N76.0

ICD-10 Finland

Acute vaginitis

1.9

132.9

1972

5372

SAA04

NOMESCO Finland

Special examination of mouth

2.0

132.7

1667

4277

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

132.7

1805

4769

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

132.6

3056

9527

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

132.6

1671

4293

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.9

132.2

1980

5411

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

183.0

132.0

179

K04.08

ICD-10 Finland

Other specified pulpit

1.7

132.0

2679

8058

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.1

131.6

274

197

-42

ICPC

Electrical tracing

4.8

131.6

393

425

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.3

131.5

618

962

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

131.5

4003

13393

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.7

131.4

398

436

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

131.1

1563

3931

R04

ICPC

Breathing problem other

2.3

130.9

1183

2649

A04AA01

ATC

ondansetron; systemic, rectal

1.8

130.9

2497

7373

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.7

130.9

844

1596

B81

ICPC

Anaemia vit B12/folate deficiency

2.4

130.5

1069

2287

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

130.4

1025

2149

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

130.3

13379

55849

M01AX05

ATC

glucosamine; oral

1.5

130.2

4961

17452

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

17.9

129.8

168

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.0

129.7

310

265

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

129.7

1602

4084

L20.0

ICD-10 Finland

Besnier prurigo

1.8

129.5

2394

7002

P15

ICPC

Chronic alcohol abuse

2.5

129.4

1007

2101

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

129.2

3747

12388

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

128.9

1426

3482

RF420, ,

NOMESCO Finland

5.0

128.9

369

383

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.8

128.7

377

400

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

6.4

128.7

290

231

R09

ICPC

Sinus symptom/complaint

1.8

128.3

2524

7520

A03FA02

ATC

cisapride; oral, rectal

1.8

128.3

2155

6116

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

128.2

2101

5916

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.6

128.0

907

1804

R51.81

ICD-10 Finland

Facial pain NOS

3.0

127.9

712

1236

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

127.8

930

1876

H3603, E103,

ICD-10 Finland

5.8

127.7

317

283

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.9

127.5

2032

5669

A97

ICPC

No disease

1.4

127.2

6834

25709

R06.2

ICD-10 Finland

Wheezing

2.1

127.1

1393

3388

T82

ICPC

Obesity

2.1

127.0

1400

3413

N06AA12

ATC

doxepin; systemic

2.1

126.6

1414

3465

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

126.3

1131

2522

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

126.1

2006

5593

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.7

126.0

813

1538

H36.01

ICD-10 Finland

Diabetic maculopathy

4.8

126.0

372

398

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

125.9

11549

47379

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.1

125.8

1410

3460

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

125.6

1002

2116

K78

ICPC

Atrial fibrillation/flutter

1.8

125.5

2092

5922

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

125.0

1163

2638

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.3

125.0

336

327

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

125.0

5160

18446

S06

ICPC

Rash localized

2.0

124.7

1710

4530

Z72.2

ICD-10 Finland

Drug use

7.4

124.4

251

173

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

124.3

1968

5478

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.1

124.0

633

1041

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

123.9

933

1915

G43.3

ICD-10 Finland

Complicated migraine

3.3

123.7

572

881

D02AE01

ATC

carbamide; topical

1.9

123.6

1880

5163

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

123.2

1188

2738

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

123.1

1503

3814

N07CA01

ATC

betahistine; oral

1.9

123.1

1972

5510

A07EA06

ATC

budesonide; oral, local oral

2.3

122.4

1154

2633

Z03.4

ICD-10 Finland

Observation for suspected myocardial infarction

57.8

122.4

124

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

122.2

5490

19952

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

122.1

3804

12783

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

122.1

1903

5268

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

122.1

943

1960

GX1K5

NOMESCO Finland

Diffusion capacity

10.4

121.9

200

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.4

121.8

1027

2227

S22.3

ICD-10 Finland

Fracture of rib

1.8

121.8

2233

6511

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

121.8

2487

7488

JAH01

NOMESCO Finland

Laparoscopy

2.2

121.5

1272

3036

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.5

121.4

964

2031

L50.0

ICD-10 Finland

Allergic urticaria

2.7

121.1

819

1589

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.4

121.1

1051

2310

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

120.8

3030

9651

J01MA01

ATC

ofloxacin; systemic

1.7

120.8

2478

7471

M10.9

ICD-10 Finland

Gout, unspecified

1.8

120.6

2067

5902

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.0

120.5

1665

4422

OAB50, ,

SPAT

1.7

120.4

2478

7477

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.9

120.4

292

254

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

9.1

120.2

212

119

D10

ICPC

Vomiting

1.8

120.2

2047

5833

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

4.6

120.2

371

414

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.1

120.2

430

546

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.2

120.1

416

514

R52.1

ICD-10 Finland

Chronic intractable pain

5.6

119.8

307

284

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.6

119.5

816

1592

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

119.4

2222

6507

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

119.2

4714

16691

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

119.0

10398

42286

H93.1

ICD-10 Finland

Tinnitus

1.8

119.0

2023

5761

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.1

118.9

425

539

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

118.8

2641

8143

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.2

118.7

1198

2815

R06AX13

ATC

loratadine; oral

1.5

118.7

4716

16713

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

118.6

2278

6735

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

118.5

1693

4549

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.1

118.3

624

1048

XA400

NOMESCO Finland

EEG

8.1

118.3

226

144

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.6

118.1

299

273

F32.8

ICD-10 Finland

Other depressive episodes

3.4

118.0

530

800

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

117.9

2162

6303

RD210, ,

NOMESCO Finland

3.5

117.7

519

773

R81

ICPC

Pneumonia

2.2

117.6

1202

2840

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

117.5

7598

29469

SPAT1058

SPAT

PEF monitoring instruction

1.8

117.4

2162

6311

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

117.2

1254

3020

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

117.1

1083

2450

L76

ICPC

Fracture: other

2.5

116.7

869

1773

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

116.7

3441

11409

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.2

116.7

1176

2762

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

116.6

1030

2282

H3601, E103,

ICD-10 Finland

6.2

116.3

271

225

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

116.1

2530

7757

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

115.8

1196

2838

B02AA02

ATC

tranexamic acid; systemic

1.5

115.6

4273

14909

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

115.4

1263

3069

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

115.1

7172

27632

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

7.5

115.1

231

158

A10BH05

ATC

linagliptin; oral

2.1

115.1

1377

3466

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

115.1

729

1365

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

115.0

1745

4786

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.5

114.7

297

278

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

114.6

1030

2300

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

114.6

2040

5892

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

114.5

2144

6289

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

114.5

1695

4610

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.9

114.5

1705

4647

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

114.4

624

1070

J01AA04

ATC

lymecycline; systemic

1.5

114.3

4356

15296

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

114.2

11360

47010

S01BC05

ATC

ketorolac; ophthalmic

2.2

114.1

1128

2627

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.0

114.1

633

1097

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

114.0

1456

3756

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.5

114.0

500

742

WX872

NOMESCO Finland

Intensive care

2.0

113.8

1442

3710

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

113.5

3819

13051

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.0

113.5

218

140

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

113.2

3410

11359

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

113.1

746

1428

N89

ICPC

Migraine

2.2

113.1

1197

2869

L04AD01

ATC

ciclosporin; systemic

3.2

112.7

551

881

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

112.7

6825

26159

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.3

112.1

538

850

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

112.0

3270

10811

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

111.9

474

686

A01AB09

ATC

miconazole; local oral

1.7

111.8

2441

7485

Z49.2

ICD-10 Finland

Other dialysis

6.1

111.5

261

218

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

111.3

2010

5830

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

110.7

2973

9628

A12AA04

ATC

calcium carbonate; oral

3.5

110.3

481

711

WX882

NOMESCO Finland

High dependency care

2.5

110.0

840

1736

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.2

110.0

1095

2558

F32

ICD-10 Finland

Depressive episode

1.9

109.9

1789

5022

L50.8

ICD-10 Finland

Other urticaria

3.3

109.8

525

827

R03AC13

ATC

formoterol; inhalant

2.0

109.7

1438

3745

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.9

109.7

645

1157

H92.0

ICD-10 Finland

Otalgia

1.8

109.5

2014

5875

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

109.3

1252

3098

R04.0

ICD-10 Finland

Epistaxis

1.7

109.3

2195

6572

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

109.2

973

2164

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

109.1

1883

5385

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

109.0

910

1964

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

109.0

3183

10522

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

108.9

7060

27350

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.4

108.9

245

195

GX1E5, ,

SPAT

4.0

108.8

390

496

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.3

108.7

969

2156

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

108.6

1453

3812

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.6

108.6

448

636

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

108.5

1605

4363

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.9

108.3

620

1095

J20

ICD-10 Finland

Acute bronchitis

1.6

108.2

3309

11058

S01

ICPC

Pain/tenderness of skin

2.0

108.1

1388

3588

B02.9

ICD-10 Finland

Zoster without complication

1.8

107.9

1915

5524

UJH02

NOMESCO Finland

Anoscopy

2.2

107.8

1091

2566

K90

ICPC

Stroke/cerebrovascular accident

2.6

107.6

786

1588

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.2

107.6

1115

2649

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

107.6

839

1752

N06AG02

ATC

moclobemide; oral

2.1

107.5

1167

2826

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

107.2

2882

9333

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

106.9

2480

7730

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.6

106.8

779

1573

L09

ICPC

Arm symptom/complaint

1.9

106.5

1488

3965

P19

ICPC

Drug abuse

4.2

106.4

367

452

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

106.3

1789

5074

R52.0

ICD-10 Finland

Acute pain

2.3

106.3

1021

2348

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

106.3

970

2181

A10BJ06

ATC

semaglutide; parenteral

1.9

106.1

1507

4039

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.9

106.0

396

521

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

106.0

1632

4497

J01CF05

ATC

flucloxacillin; systemic

1.7

105.9

2240

6805

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

105.6

1602

4392

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

105.4

2508

7869

N39.3

ICD-10 Finland

Stress incontinence

1.9

105.3

1708

4788

A13

ICPC

Concern/fear medical treatment

3.0

105.2

577

993

NG1EA, ,

SPAT

4.7

105.1

316

344

L84

ICPC

Back syndrome without radiat pain

2.0

104.9

1399

3666

SPAT1043

SPAT

Audiometry

1.7

104.8

2494

7826

A02BA04

ATC

nizatidine; systemic

1.7

104.7

2079

6202

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.5

104.5

769

1560

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

104.2

2172

6571

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.4

104.1

900

1974

R04.2

ICD-10 Finland

Haemoptysis

2.3

104.1

979

2231

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.9

104.1

613

1101

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

104.0

5619

21084

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

103.8

1316

3385

K03.00

ICD-10 Finland

Approximal wear

1.7

103.7

2456

7696

S01.0

ICD-10 Finland

Open wound of scalp

1.7

103.5

2524

7970

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

103.5

11826

49728

R32

ICD-10 Finland

Unspecified urinary incontinence

2.6

103.5

733

1458

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.9

103.4

1588

4371

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

103.3

526

864

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

3.3

103.2

483

750

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.2

103.2

509

819

XF602

NOMESCO Finland

Bloodpressure monitoring

4.0

103.1

370

471

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

6.3

103.0

236

192

J02AC02

ATC

itraconazole; systemic

1.4

102.9

5193

19243

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

102.6

2982

9839

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

102.6

683

1314

R49.08

ICD-10 Finland

Other specified dysphonia

2.9

102.5

610

1102

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

102.5

1037

2439

NG2AA

NOMESCO Finland

Patella X-ray examination

2.5

102.4

774

1591

F06.7

ICD-10 Finland

Mild cognitive disorder

2.5

102.4

797

1663

EC1VA, ,

NOMESCO Finland

1.9

102.2

1474

3971

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

102.0

1770

5068

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.0

101.9

1248

3169

SPAT1285

SPAT

Provision of consultation response

1.9

101.8

1428

3810

A23

ICPC

Risk factor NOS

1.6

101.7

3226

10864

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

101.7

547

930

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.0

101.5

547

931

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.5

101.4

187

113

F43.00

ICD-10 Finland

Acute stress reaction mild

2.6

101.2

737

1487

R10.0

ICD-10 Finland

Acute abdomen

2.2

101.2

1019

2392

B05DA

ATC

Isotonic solutions

5.7

101.1

254

230

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

101.1

1409

3750

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.0

101.1

1363

3585

F93.89

ICD-10 Finland

Other childhood emotional disorders

5.6

101.1

257

236

R19.5

ICD-10 Finland

Other faecal abnormalities

3.2

101.0

492

785

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.9

100.8

373

487

S22

ICPC

Nail symptom/complaint

1.7

100.7

2020

6042

K05.30

ICD-10 Finland

Periodontitis complex

1.5

100.7

4489

16244

I20.09

ICD-10 Finland

Unstable angina

1.9

100.5

1591

4423

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.4

100.4

864

1891

IHZ05, ,

SPAT

1.9

100.4

1554

4288

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.0

100.3

542

924

M54

ICD-10 Finland

Dorsalgia

1.5

100.3

4220

15098

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

100.3

1558

4305

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.2

100.2

489

781

R15

ICD-10 Finland

Faecal incontinence

2.7

100.1

665

1278

F10.24

ICD-10 Finland

Alcohol depence active use

3.1

99.9

510

839

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.2

99.8

338

410

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

99.6

2329

7271

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

99.6

506

830

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.1

99.6

1125

2768

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.0

99.5

1347

3549

137

Kela drug reimbursment

Uraemia requiring dialysis

4.8

99.4

292

311

N06AA10

ATC

nortriptyline; systemic

2.8

99.4

594

1076

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.1

99.3

512

848

R30.1

ICD-10 Finland

Vesical tenesmus

2.7

99.3

669

1296

F40.1

ICD-10 Finland

Social phobias

2.4

99.0

847

1849

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.3

98.6

934

2135

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.1

98.5

1077

2615

L50.9

ICD-10 Finland

Urticaria, unspecified

2.1

98.5

1153

2877

A27

ICPC

Fear of other disease NOS

1.9

98.5

1465

3989

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.6

98.4

690

1365

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

98.4

607

1120

D07AA02

ATC

hydrocortisone; topical

1.4

98.3

4532

16500

TGC00

NOMESCO Finland

Bronchial lavation

2.6

98.2

709

1424

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

98.2

3501

12099

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

98.2

4022

14309

P18

ICPC

Medication abuse

5.5

98.1

253

236

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

98.1

4088

14594

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.8

98.0

1651

4683

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.2

98.0

941

2164

SPAT1236

SPAT

Informing family of child’s disability

2.9

97.8

574

1029

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.7

97.8

630

1191

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

97.7

1285

3350

Z2221

NOMESCO Finland

Medical doctor

1.3

97.6

8600

34846

Y96.8

ICD-10 Finland

Other type of accident

5.2

97.6

264

259

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

97.5

856

1891

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.0

97.3

544

947

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.5

97.2

412

597

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

97.0

1473

4038

-57

ICPC

Physical medicine/rehabilitation

10.0

96.9

162

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

96.9

1112

2753

C10AA04

ATC

fluvastatin; oral

1.7

96.9

2212

6861

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.5

96.7

248

230

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

96.6

2213

6869

I49.1

ICD-10 Finland

Atrial premature depolarization

2.2

96.5

1029

2473

JN3AE, ,

SPAT

2.0

96.4

1259

3273

R25.1

ICD-10 Finland

Tremor, unspecified

2.3

96.4

880

1979

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

96.4

2093

6403

ZXA10

NOMESCO Finland

Bilateral

1.4

96.3

5171

19358

SPAT1059

SPAT

Spirometry at the office

2.0

96.3

1277

3339

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.8

96.2

610

1143

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

95.8

2153

6648

N05AB03

ATC

perphenazine; systemic, rectal

2.2

95.6

1015

2435

R78

ICPC

Acute bronchitis/bronchiolitis

2.8

95.6

606

1135

RF120, ,

NOMESCO Finland

4.5

95.5

304

349

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

95.5

3002

10084

F45.0

ICD-10 Finland

Somatization disorder

8.3

95.4

179

111

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.6

95.3

395

563

M01AB55

ATC

diclofenac, combinations; oral

1.8

95.3

1722

4992

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

95.3

2102

6458

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.5

95.2

3184

10846

-, ,

ICD-10 Finland

2.8

95.2

577

1054

D07XC01

ATC

betamethasone; topical

1.5

95.1

3586

12538

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.1

95.0

496

828

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

94.8

739

1543

F03

ICPC

Eye discharge

1.7

94.7

2041

6229

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

94.7

1621

4620

R5599

NOMESCO Finland

Other rehabilitation service

2.6

94.6

660

1302

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

94.6

576

1055

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

94.5

3792

13428

PD5AD

NOMESCO Finland

CT of aorta

2.5

94.5

715

1471

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

94.5

3390

11727

OAB93, ,

SPAT

1.7

94.4

2249

7055

G04CB01

ATC

finasteride; oral

1.5

94.1

3191

10902

WZC00, ,

SPAT

1.4

94.1

4745

17559

G54.0

ICD-10 Finland

Brachial plexus disorders

2.5

93.9

739

1550

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.1

93.8

476

780

N05AH02

ATC

clozapine; systemic

2.7

93.7

602

1136

A10AA02, ,

ATC

2.2

93.7

917

2126

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.8

93.7

277

297

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

93.6

943

2214

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

93.4

3694

13040

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.8

93.4

277

298

H60.3

ICD-10 Finland

Other infective otitis externa

2.5

93.1

694

1417

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.0

93.0

341

442

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.8

93.0

1750

5136

WZC30, ,

SPAT

1.6

93.0

2513

8141

JN4BD

NOMESCO Finland

Extensive body CT

1.6

92.9

2847

9505

R01AD01

ATC

beclometasone; nasal

1.4

92.6

4435

16253

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

92.5

1039

2550

M75.8

ICD-10 Finland

Other shoulder lesions

2.0

92.4

1157

2961

XQ801

NOMESCO Finland

Intracutantest

16.9

92.4

122

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.5

92.3

406

604

C02AC05

ATC

moxonidine; oral

2.0

92.2

1217

3176

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

92.2

1032

2530

J01FA15

ATC

telithromycin; oral

1.6

92.1

2830

9453

SPAT1283

SPAT

Restricted health certificate

1.4

92.0

5778

22205

ZX112

NOMESCO Finland

Subcutaneous

2.8

91.8

575

1070

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

91.8

981

2360

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.2

91.7

973

2334

DFF59

NOMESCO Finland

Other assessment of balance

4.8

91.6

272

293

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

91.6

1071

2671

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

91.4

3183

10936

L20

ICPC

Joint symptom/complaint NOS

2.0

91.3

1121

2848

IGY02, ,

SPAT

2.9

91.3

538

967

I49.5

ICD-10 Finland

Sick sinus syndrome

2.1

91.2

1004

2445

L84

ICD-10 Finland

Corns and callosities

2.2

90.9

962

2305

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.1

90.7

1083

2723

K28

ICPC

Limited function/disability (K)

2.7

90.6

608

1175

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.5

90.6

286

326

K85

ICPC

Elevated blood pressure

1.4

90.6

4687

17416

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.8

90.6

345

461

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.4

90.6

409

620

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.1

90.5

1078

2707

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.6

90.5

629

1239

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

90.2

1217

3202

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.0

90.2

257

266

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

13.0

90.1

132

R25.2

ICD-10 Finland

Cramp and spasm

2.4

90.0

751

1620

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.3

89.9

302

364

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.8

89.7

221

196

L99

ICPC

Musculoskeletal disease other

2.5

89.7

661

1342

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

89.7

941

2247

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

89.6

2398

7748

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

89.5

617

1210

S12

ICPC

Insect bite/sting

1.6

89.5

2401

7762

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.6

89.4

2385

7698

R06AX26

ATC

fexofenadine; oral

1.7

89.2

2007

6198

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

88.9

2446

7957

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

88.7

1701

5019

NH1AD

NOMESCO Finland

Ankle and foot CT

2.5

88.6

674

1390

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.6

88.6

636

1274

M89.0

ICD-10 Finland

Algoneurodystrophy

4.9

88.5

257

271

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

47.1

88.5

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.1

88.3

969

2356

K05

ICPC

Irregular heartbeat other

2.2

88.3

848

1950

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

88.3

7027

28001

E87.6

ICD-10 Finland

Hypokalaemia

2.1

88.3

973

2370

G43.8

ICD-10 Finland

Other migraine

3.0

88.2

490

850

K05.18

ICD-10 Finland

Chronic gingivitis

1.6

88.1

2381

7710

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

87.9

1388

3854

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

87.8

4759

17823

H26.4

ICD-10 Finland

After-cataract

1.6

87.6

2494

8178

Z31.5

ICD-10 Finland

Genetic counselling

1.8

87.5

1604

4668

N18

ICPC

Paralysis/weakness

2.7

87.5

558

1049

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

87.4

2474

8102

R75

ICPC

Sinusitis acute/chronic

1.9

87.3

1366

3782

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

87.1

3133

10834

S82

ICPC

Naevus/mole

1.4

87.0

4384

16204

S20.2

ICD-10 Finland

Contusion of thorax

1.8

87.0

1649

4848

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

86.9

701

1488

NA3AA, ,

SPAT

2.0

86.8

1194

3163

M03BX01

ATC

baclofen; systemic

2.8

86.7

538

996

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.3

86.6

812

1848

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.0

86.5

1053

2667

A92

ICPC

Allergy/allergic reaction NOS

2.1

86.4

938

2271

ZX100

NOMESCO Finland

Oral

3.5

86.3

380

566

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.0

86.3

309

393

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.7

86.3

2019

6299

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.7

86.2

566

1081

L57.0

ICD-10 Finland

Actinic keratosis

1.6

86.2

2737

9207

A07EC02

ATC

mesalazine; oral, rectal

1.8

86.2

1596

4659

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

86.2

4239

15598

V03AE01

ATC

polystyrene sulfonate; oral

3.4

86.1

391

595

K99

ICPC

Cardiovascular disease other

2.4

85.9

716

1544

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

85.7

1590

4645

D03

ICPC

Heartburn

2.0

85.5

1066

2724

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

10.8

85.5

137

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.6

85.1

217

200

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

85.0

893

2133

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

85.0

1389

3900

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.0

84.9

1123

2933

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.4

84.7

721

1570

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.8

84.6

331

452

183

Kela drug reimbursment

Lamotrigin and topiramate

4.3

84.6

283

340

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

84.5

605

1210

L60.0

ICD-10 Finland

Ingrowing nail

1.8

84.5

1410

3985

M77.4

ICD-10 Finland

Metatarsalgia

1.7

84.4

1769

5354

-60

ICPC

Result test/procedure

1.8

84.4

1473

4223

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

84.4

768

1725

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.3

84.2

797

1821

D01AE16

ATC

amorolfine; topical

1.5

84.1

3198

11187

J01MA06

ATC

norfloxacin; oral

1.5

84.0

3640

13072

XQ899

NOMESCO Finland

Other assessment of skin

11.4

83.9

131

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

83.8

659

1382

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

83.8

1163

3090

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

83.7

1137

2998

E86

ICD-10 Finland

Volume depletion

2.3

83.6

729

1606

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

83.5

735

1626

P27

ICPC

Fear of mental disorder

3.1

83.5

423

693

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

83.5

959

2375

B05DB

ATC

Hypertonic solutions

5.3

83.2

222

215

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

83.0

738

1640

E000006, ,

ATC

1.7

82.9

1795

5482

XQ820

NOMESCO Finland

Exposure to medicinal substance

16.2

82.9

111

L10

ICPC

Elbow symptom/complaint

1.7

82.8

1724

5208

XQ902

NOMESCO Finland

Other photography

3.8

82.6

319

431

WW200, ,

SPAT

1.3

82.6

9505

39778

I50.0

ICD-10 Finland

Congestive heart failure

1.6

82.6

2144

6870

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

82.6

485

870

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.5

82.5

612

1247

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

82.4

1579

4656

Z03

ICPC

Housing/neighbourhood problem

5.2

82.4

222

217

R07.2

ICD-10 Finland

Precordial pain

2.6

82.3

585

1166

ZX108, ,

SPAT

13.9

82.3

117

C08DA01

ATC

verapamil; systemic

2.0

82.3

1131

2995

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.6

82.1

577

1143

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

82.1

1316

3671

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

81.9

668

1426

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.0

81.8

435

735

R4190

NOMESCO Finland

Nutritional therapy

2.0

81.7

1120

2962

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

81.5

661

1407

Z13.6

ICD-10 Finland

Special screening examination for cardiovascular disorders

8.4

81.5

151

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.5

81.4

624

1292

K04.09

ICD-10 Finland

Pulpit UNS

1.8

81.4

1422

4078

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.2

81.2

821

1930

P16

ICPC

Acute alcohol abuse

2.7

81.2

537

1030

J01FA01

ATC

erythromycin; systemic

1.4

81.1

4423

16567

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.6

81.1

338

484

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

81.1

1388

3955

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

81.0

1291

3595

A07AA09

ATC

vancomycin; oral

3.1

80.9

412

677

IBA01, ,

SPAT

2.4

80.8

647

1369

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

80.8

1916

5998

R4180, ,

SPAT

3.8

80.7

314

427

M05BX04

ATC

denosumab; parenteral

1.8

80.7

1430

4119

L18

ICPC

Muscle pain

1.9

80.5

1273

3535

Angiography of the heart and coronary arteries

1.7

80.5

1583

4703

IHZ04, ,

SPAT

2.6

80.5

580

1164

N80

ICPC

Head injury other

2.5

80.2

606

1246

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.3

80.2

754

1718

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

80.2

2695

9178

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

80.0

2726

9312

C07AG02

ATC

carvedilol; oral

1.8

79.8

1554

4605

XG460

NOMESCO Finland

Short time oxymetry

3.0

79.7

440

761

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

79.6

821

1946

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

79.6

704

1561

G50.1

ICD-10 Finland

Atypical facial pain

2.9

79.6

453

798

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.6

79.5

334

481

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1912

3463

2.90

322.13

1.4

1.2

—

(3022145) Colonoscopy Study observation

5684

16655

1.85

319.54

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

925

976

4.92

317.79

3.4

2.9

57.78

58.18

0.16

760

852

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1099

1374

4.16

313.19

1.9

1.6

394.18

393.49

mu/l

0.01

850

1131

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5722

16942

1.83

310.70

2.0

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1648

2789

3.10

310.11

1.3

1.2

3.85

6.57

u/ml

0.54

108

181

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1913

3553

2.83

308.47

1.5

1.4

12.47

11.25

iu/ml

0.13

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

20818

76831

1.72

307.65

3.1

2.6

—

estimate

—

(3018010) Neutrophils/Leukocytes in Blood

23364

74696

2.26

307.65

7.8

5.4

57.32

57.31

0.05

22359

71533

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

4808

10893

2.41

307.65

3.3

2.4

66.43

69.88

ml/min/173m2

4.70

1745

4753

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

37259

163807

2.00

307.65

5.7

4.2

5.97

5.81

mmol/l

85.90

34539

151135

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2673

3853

3.71

307.65

2.1

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

10833

34342

1.81

307.65

3.2

2.4

5.01

5.96

e6/l

8.75

10155

30645

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

12216

35776

2.03

307.65

1.4

1.3

1.65

1.75

u/ml

0.34

3047

10466

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

21109

64568

2.28

307.65

2.3

1.9

97.92

94.90

pmol/l

13.98

11948

34012

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

38285

164738

2.34

307.65

18.7

12.2

84.05

84.39

ml/min/173m2

2.05

36036

148277

(3001122) Ferritin [Mass/volume] in Serum or Plasma

22477

80923

1.85

307.65

3.8

2.7

125.41

120.76

ug/l

1.25

21057

75868

(3019069) Monocytes/Leukocytes in Blood

23192

73972

2.26

307.65

8.1

5.6

8.79

8.80

0.26

21906

69313

(3014051) Protein [Presence] in Urine by Test strip

13390

48362

1.59

307.65

3.5

2.5

0.08

0.06

0.39

342

1048

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

14977

38923

2.46

307.65

3.7

2.8

1410.52

1457.36

ng/l

0.50

12629

33027

(3012544) pH of Venous blood

5716

14614

2.15

307.65

5.2

3.3

7.38

2.57

3834

7369

(3018418) pH of Serum or Plasma

12960

46398

1.60

307.65

5.2

3.7

7.39

7.40

51.15

9928

30790

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4197

9219

2.46

307.65

4.9

3.4

92.01

87.27

ng/l

2.01

3665

7921

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

38105

175877

1.75

307.65

6.0

4.9

2.66

2.79

mmol/l

132.82

35662

164916

(3022948) Iron [Moles/volume] in Serum or Plasma

9447

24349

2.25

307.65

3.1

2.2

13.28

13.49

umol/l

1.52

8844

22509

(3037121) Protein [Mass/volume] in Urine

2131

3948

2.85

307.65

3.3

3.6

428.16

499.85

mg/l

0.38

916

2107

(3007853) Bacteria identified in Skin by Aerobe culture

6260

16961

2.03

307.65

2.0

1.6

—

(3035941) MCH [Entitic mass]

41721

197556

2.27

307.65

31.7

17.8

30.29

30.25

4.41

41349

195151

(3009508) Creatinine [Moles/volume] in Urine

15551

52243

1.80

307.65

4.2

3.1

7.79

8.08

mmol/l

9.08

13067

44259

(3001604) Monocytes [#/volume] in Blood

24978

79870

2.36

307.65

7.8

5.4

0.58

0.59

e9/l

0.84

22396

66659

(3026361) Erythrocytes [#/volume] in Blood

41722

197588

2.27

307.65

31.8

17.9

4.49

4.55

e12/l

108.10

41121

191504

(3026493) Urate [Moles/volume] in Serum or Plasma

12124

42203

1.64

307.65

3.1

2.4

346.11

343.45

umol/l

1.80

10740

37580

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7037

21388

1.81

307.65

2.0

1.6

1.49

1.38

24.57

6264

18951

(3018095) Leukocytes [#/volume] in Urine

17138

60987

1.71

307.65

4.7

3.3

77.29

102.02

e6/l

3.57

13114

39934

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1013

1079

4.89

307.65

1.5

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7483

14398

2.99

307.65

5.3

4.2

32.10

31.76

1.42

5130

9630

(40758558) Short blood count panel - Blood

14750

46183

1.95

307.65

8.1

5.4

—

(3009261) Glucose [Presence] in Urine by Test strip

22965

91294

1.59

307.65

4.6

3.2

0.11

0.19

estimate

0.29

3976

18758

(3000330) Specific gravity of Urine by Test strip

3478

6542

2.86

307.65

3.7

2.9

1.02

ratio

13.26

3266

5675

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8216

20829

2.25

307.65

3.1

2.3

22.72

23.31

2.90

7681

19182

(3022621) pH of Urine by Test strip

4759

12095

2.13

307.65

2.8

2.3

6.02

6.13

12.06

3339

7836

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

18511

56251

2.17

307.65

4.5

3.2

94.16

57.56

ng/l

0.69

12885

35959

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3063

3780

4.37

307.65

4.2

3.2

24.62

24.83

mmol/l

2.64

2811

3488

(3037467) Urinalysis macro (dipstick) panel - Urine

30121

113422

2.10

307.65

5.6

3.7

1.75

2.48

1.14

235

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1070

1162

4.80

307.65

1.5

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

9186

27854

1.86

307.65

1.4

1.3

36.66

37.50

iu/ml

0.06

2607

8493

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7168

18302

2.19

307.65

7.8

4.9

1.06

1.03

mmol/l

8.63

6688

16972

(3035350) Ketones [Presence] in Urine by Test strip

22979

90502

1.61

307.65

4.6

3.2

4.48

3.10

estimate

0.54

4167

19621

(3031040) Bacteria [#/volume] in Urine by Automated count

28784

107141

2.06

307.65

5.6

3.8

1628.64

1467.64

e6/l

0.11

212

2166

(3002032) Base excess in Venous blood by calculation

5601

13952

2.20

307.65

5.2

3.3

1.92

1.71

mmol/l

3.64

4899

12264

(4146454) Self-monitoring of blood glucose

1206

605

10.44

307.65

3.2

2.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

20676

67815

2.04

307.65

5.9

4.5

35.97

35.78

g/l

4.29

19428

63260

(3014111) Lactate [Moles/volume] in Serum or Plasma

5109

13355

2.08

307.65

8.2

7.8

1.36

1.35

mmol/l

0.27

5014

13098

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

13733

37930

2.23

307.65

2.7

2.1

2.83

2.77

mg/l

1.73

11842

32402

(3037522) Nuclear Ab [Titer] in Serum

7920

20258

2.21

307.65

1.5

1.3

508.36

504.89

titre

0.05

1715

3745

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

40718

187238

2.31

307.65

15.0

9.4

27.42

27.02

u/l

1.66

39678

181566

(3017143) Hepatitis C virus Ab [Presence] in Serum

6598

20006

1.80

307.65

1.8

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

37543

172411

1.72

307.65

5.5

4.3

1.41

1.45

mmol/l

46.43

35106

161557

(3021601) Nitrite [Presence] in Urine by Test strip

22647

89451

1.60

307.65

4.5

3.2

0.00

estimate

1.30

4089

19419

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

29653

122062

1.72

307.65

4.3

2.7

50.41

44.82

u/l

17.92

28098

115485

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

33518

123369

2.57

307.65

10.0

6.9

78.91

78.98

u/l

0.08

32101

116369

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4237

9638

2.38

307.65

2.5

2.3

20.55

20.76

au/ml

0.06

488

1264

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8499

25350

1.88

307.65

1.4

1.3

10.65

10.89

u/ml

0.10

3209

10358

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7729

22280

1.93

307.65

2.5

1.9

29.67

29.80

0.91

7553

21689

(3042936) Bacteria identified in Isolate by Culture

7272

20963

1.92

307.65

2.3

1.8

—

(3005322) IgE [Units/volume] in Serum or Plasma

3758

8869

2.27

307.65

1.4

1.2

258.10

260.50

u/ml

0.02

3522

8244

(3045424) Erythrocytes [Presence] in Urine

2936

5356

2.93

307.65

2.3

1.8

0.42

0.05

estimate

0.47

645

1867

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1055

1131

4.86

307.65

1.5

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1011

1078

4.88

307.65

1.5

1.3

—

(3010813) Leukocytes [#/volume] in Blood

41739

197613

2.28

307.65

31.9

17.9

6.87

6.70

e9/l

33.69

41137

191498

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4066

9505

2.30

307.65

1.8

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

8724

22061

2.27

307.65

1.8

1091.18

1203.38

nmol/l

20.43

6533

16629

(3019550) Sodium [Moles/volume] in Serum or Plasma

40082

173620

2.81

307.65

23.7

14.0

139.60

139.69

mmol/l

8.99

39398

169317

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9514

27599

1.97

307.65

4.4

3.3

355.72

603.03

ng/l

5.96

7096

21047

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5554

14274

2.13

307.65

5.2

3.3

5.86

5.81

kpa

2.54

5427

13938

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4760

10527

2.47

307.65

2.7

2.2

0.43

0.39

e6/l

0.44

4637

9841

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2956

6538

2.40

307.65

5.0

3.5

48.94

47.34

2.44

2921

6443

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8013

25251

1.76

307.65

3.5

2.7

2.43

2.80

e6/l

1.64

4861

10230

(3023520) Reticulocytes [#/volume] in Blood

4940

11685

2.30

307.65

2.8

2.5

70.28

68.67

e9/l

1.97

3861

8041

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2897

4172

3.73

307.65

2.2

1.7

—

(3022096) Basophils/Leukocytes in Blood

23136

73813

2.25

307.65

8.1

5.6

0.68

0.67

4.43

21836

69018

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16182

54513

1.81

307.65

3.8

2.8

34.72

34.14

u/l

0.17

15290

51334

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5269

13502

2.13

307.65

2.8

2.0

0.21

g/l

0.89

4883

12562

(40768797) Stomach Pathology biopsy report

7156

17566

2.29

307.65

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

40117

174137

2.80

307.65

23.9

14.1

3.97

3.96

mmol/l

8.39

39365

169445

(3002582) Erythrocytes [#/volume] in Urine

15277

51883

1.77

307.65

4.1

2.9

62.18

100.66

e6/l

2.74

12612

37118

(36304419) Bacteria [Presence] in Urine

12347

43649

1.62

307.65

3.8

2.8

3.54

1.94

estimate

0.28

165

(3012516) Albumin [Mass/volume] in Urine

13844

47354

1.72

307.65

4.1

3.2

55.79

49.07

mg/l

2.21

8898

29859

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6384

13863

2.58

307.65

7.4

5.6

—

(3045414) Leukocytes [Presence] in Urine

6197

10960

3.19

307.65

2.3

1.8

0.02

0.04

estimate

1.51

896

2476

(4024509) Urine culture

3142

4854

3.48

307.65

2.2

1.6

—

(3017732) Neutrophils [#/volume] in Blood

7639

16915

2.58

307.65

3.6

2.7

4.47

4.52

e9/l

0.18

6427

14981

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2025

3751

2.84

307.65

1.3

1.2

36.70

39.34

u/ml

0.12

107

213

(3013512) EKG study

17449

45474

2.58

307.65

4.2

3.2

0.75

0.72

0.17

102

(3000494) Fungus identified in Specimen by Culture

6055

17927

1.84

307.65

1.7

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

10941

30912

2.07

307.65

1.6

1.4

2.34

2.38

g/l

1.09

6876

20064

(3002030) Lymphocytes/Leukocytes in Blood

23474

77161

2.17

307.65

8.0

5.5

27.82

27.96

1.05

22517

72958

(3015736) pH of Urine

19033

71572

1.63

307.65

4.1

2.8

6.27

6.15

39.12

11411

38678

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6071

12525

2.71

307.65

2.5

2.3

367.19

387.48

nmol/l

9.94

5539

11779

(3032080) INR in Blood by Coagulation assay

22305

68270

2.34

307.65

15.7

12.8

1.24

inr

0.94

19145

55624

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

16246

46533

2.23

307.65

3.3

2.4

60.84

65.63

u/l

0.56

15158

42977

(3020630) Protein [Mass/volume] in Serum or Plasma

4375

10829

2.18

307.65

2.6

2.4

66.61

66.40

g/l

0.85

3981

9998

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

11614

32974

2.08

307.65

2.1

1.6

1.12

1.28

mg/l

3.91

8783

25573

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

37764

173434

1.74

307.65

5.5

4.4

4.53

4.70

mmol/l

186.55

35447

163528

(3013115) Eosinophils [#/volume] in Blood

25765

82658

2.41

307.65

8.1

5.5

0.19

e9/l

0.14

23120

70632

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

36366

162341

1.79

307.65

4.8

3.7

1.32

1.28

mmol/l

23.70

33752

151064

(3021960) Folate [Moles/volume] in Serum or Plasma

13927

39873

2.14

307.65

1.8

1.6

19.78

19.63

nmol/l

0.52

11979

34032

(3006315) Basophils [#/volume] in Blood

25080

80001

2.38

307.65

7.8

5.4

0.04

e9/l

2.76

22488

66716

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2573

4512

3.03

307.65

2.4

2.2

438.19

679.90

ug/l

2.09

2412

4281

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

21575

69088

2.16

307.65

2.8

2.2

4254.40

75.67

nmol/l

0.50

19623

63108

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

39936

174106

2.68

307.65

21.3

11.9

22.73

25.59

mg/l

51.98

34407

137940

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1055

1115

4.93

307.65

1.5

1.3

—

(3009343) pH of Capillary blood

4548

8041

3.10

307.65

4.1

3.1

7.41

7.42

9.29

3782

6595

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8537

24582

1.96

307.65

4.1

3.2

0.82

mmol/l

3.39

8010

23103

(3020682) Albumin/Creatinine [Ratio] in Urine

14096

48365

1.72

307.65

4.8

3.9

10.22

8.02

mg/mmol

4.64

8998

29566

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16179

42527

2.48

307.65

2.6

2.0

206.67

232.19

u/l

2.09

15438

40007

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8792

22727

2.22

307.65

3.0

2.2

2.34

2.33

g/l

1.19

8193

20719

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1014

1082

4.88

307.65

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

37494

158062

2.35

307.65

6.3

4.4

1.85

1.89

mu/l

6.41

35106

146473

(3048689) Calprotectin [Mass/mass] in Stool

7402

19199

2.16

307.65

2.6

123.19

135.87

ug/g

2.19

5925

15430

(3019198) Lymphocytes [#/volume] in Blood

25452

82450

2.35

307.65

7.8

5.4

1.90

1.93

e9/l

1.30

23110

71041

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

32294

119222

2.40

307.65

5.3

3.5

11.57

11.13

mm/h

6.07

30368

111207

(3000963) Hemoglobin [Mass/volume] in Blood

41728

197658

2.27

307.65

32.1

18.0

135.04

136.93

g/l

113.94

41353

195330

(3027945) Reticulocytes/Erythrocytes in Blood

6109

16181

2.08

307.65

2.9

2.4

1.80

1.72

6.47

5357

14419

(3007461) Platelets [#/volume] in Blood

41715

197416

2.28

307.65

31.9

17.9

251.31

251.92

e9/l

1.02

41198

192087

(3028026) IgM [Mass/volume] in Serum or Plasma

3575

8139

2.35

307.65

2.0

1.9

1.29

1.31

g/l

0.19

3273

7495

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6444

16102

2.22

307.65

5.2

4.1

235.95

246.94

u/l

5.42

6062

15355

(3023368) Bacteria identified in Blood by Culture

13510

42085

1.92

307.65

4.7

4.1

—

(3006504) Eosinophils/Leukocytes in Blood

23167

73725

2.26

307.65

8.0

5.6

2.87

2.80

3.89

21879

69053

(3030467) Casts [#/volume] in Urine by Automated count

13110

45340

1.68

307.65

3.9

2.8

0.35

0.47

e6/l

7.00

10482

30881

(3013826) Glucose [Moles/volume] in Serum or Plasma

27540

92467

2.37

307.65

6.1

4.4

6.71

6.62

mmol/l

7.56

26300

86318

(3011397) Hemoglobin [Presence] in Urine by Test strip

11451

37890

1.73

307.65

4.4

3.1

0.22

0.26

0.11

114

402

(3024731) MCV [Entitic mean volume] in Red Blood Cells

41722

197555

2.27

307.65

31.7

17.9

90.94

90.62

36.48

41350

195148

(3024354) Oxygen [Partial pressure] in Venous blood

4685

11898

2.13

307.65

4.4

2.7

4.62

4.52

kpa

1.93

4562

11573

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4012

6974

3.13

307.65

4.0

3.0

1.34

2.02

mmol/l

19.84

2951

5036

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4842

9442

2.82

307.65

2.6

2.0

7.08

8.68

ug/l

3.68

4065

8322

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2626

5442

2.56

307.65

2.1

1.9

40.05

39.59

u/l

0.46

2354

4869

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6380

17576

2.00

307.65

1.9

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9191

27054

1.93

307.65

3.4

2.7

1.07

1.30

e6/l

0.82

6075

12095

(3013650) Neutrophils [#/volume] in Blood by Automated count

27006

91766

2.28

307.65

11.1

8.6

4.13

4.20

e9/l

4.28

24358

77070

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4659

8189

3.13

307.65

4.1

3.1

5.14

kpa

0.19

4403

7829

(3019225) pH of Specimen

6554

9996

3.76

307.65

5.0

3.4

7.37

7.34

16.56

4748

7048

(3020564) Creatinine [Moles/volume] in Serum or Plasma

41116

188055

2.54

307.65

26.0

15.3

79.61

76.46

umol/l

49.64

40640

185524

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

36552

160651

1.91

307.65

7.3

5.1

39.43

38.25

mmol/mol

99.47

34290

150835

(3015377) Calcium [Moles/volume] in Serum or Plasma

15238

52752

1.72

307.65

3.4

3.6

2.35

mmol/l

2.62

13671

48453

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

32806

130074

2.10

307.65

5.0

3.8

14.75

14.64

pmol/l

12.13

30445

119072

(3020779) Urea [Moles/volume] in Serum or Plasma

4970

12306

2.20

307.65

10.2

5.8

9.84

9.80

mmol/l

0.11

4730

11723

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6200

17163

1.98

307.65

3.4

2.4

7.78

9.40

umol/l

5.74

5464

14896

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

25064

80031

2.37

307.65

7.4

5.9

11.15

12.11

umol/l

20.77

23894

75916

(3005719) IgG [Mass/volume] in Serum or Plasma

4623

10352

2.43

307.65

3.0

2.6

10.48

10.80

g/l

4.82

4305

9432

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

24210

72711

2.54

307.65

9.0

5.9

1.21

mmol/l

0.64

21679

60250

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

21411

66030

2.27

307.65

8.0

5.8

1.21

mmol/l

6.16

19752

61163

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

16473

57866

1.72

307.65

4.1

2.9

1.59

1.39

e6/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9095

23242

2.26

307.65

2.1

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

41724

197563

2.27

307.65

32.5

18.3

40.59

41.61

5.50

41336

195047

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3948

8900

2.39

307.65

1.3

1.2

47.88

52.17

au/ml

0.51

206

665

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12495

37888

1.95

307.65

2.9

2.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1897

3515

2.84

307.12

1.4

1.2

6.27

8.69

u/ml

0.79

280

448

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1894

3522

2.83

304.70

1.3

1.2

4.35

10.07

u/ml

1.17

178

292

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2283

4699

2.56

304.53

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2322

4822

2.54

304.36

2.3

2.1

7.36

7.37

g/l

0.11

2102

4431

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2319

4814

2.54

304.19

2.3

2.2

4.24

4.18

g/l

1.88

2102

4432

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2315

4810

2.54

303.10

2.3

2.2

3.65

3.86

g/l

7.19

2098

4425

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1678

2920

3.01

301.85

1.3

1.2

10.06

17.64

u/ml

0.45

(36660697) Celiac disease serology panel - Serum

4371

11928

1.97

301.78

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

10566

37413

1.58

296.96

4.5

3.2

1.15

1.11

kg/l

0.11

7577

22360

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2792

6406

2.31

296.83

1.9

1.6

0.29

0.32

mg/l

1.27

1318

3215

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5045

14563

1.87

295.23

3.0

2.3

35.31

49.16

u/l

1.54

4292

12441

(3033658) Prothrombin time (PT) actual/Normal

11649

42258

1.55

294.53

5.1

3.6

89.95

89.57

0.80

11346

41368

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1839

3432

2.81

293.83

1.4

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2664

6018

2.34

292.98

1.9

1.6

1.51

1.53

g/l

0.36

2288

5123

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

3980

10623

2.00

291.58

1.6

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1844

3474

2.79

289.70

1.5

1.4

282.07

269.04

ug/g

1.44

1036

2022

(3003129) Base excess in Capillary blood by calculation

975

1180

4.29

288.49

2.3

1.9

0.33

0.54

mmol/l

0.76

935

1142

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2529

5617

2.38

288.38

1.5

10.38

12.92

iu/ml

0.42

141

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3391

8557

2.11

287.53

5.3

3.4

24.28

24.19

mmol/l

0.81

3339

8453

(3023420) DNA double strand Ab [Units/volume] in Serum

2505

5574

2.37

284.42

2.0

1.7

6.60

7.80

iu/ml

0.97

627

1104

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3555

9284

2.04

275.40

3.6

4.50

4.56

pmol/l

2.38

3156

8470

(3004616) Nuclear Ab [Presence] in Serum

988

1276

4.02

270.54

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2158

4595

2.47

268.29

2.4

2.2

2.84

2.98

g/l

7.37

1941

4207

(3027801) Oxygen [Partial pressure] in Arterial blood

5426

16506

1.77

266.71

8.5

7.8

12.35

12.59

kpa

2.22

5217

15806

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5429

16518

1.77

266.71

8.5

7.8

5.11

5.08

kpa

1.38

5231

15827

(3019977) pH of Arterial blood

5427

16610

1.76

260.92

8.6

7.8

7.41

7.42

3.76

3051

7881

(3003396) Base excess in Arterial blood by calculation

5398

16557

1.76

257.37

8.5

7.7

0.85

0.80

mmol/l

0.37

4399

13746

(3021589) Normoblasts [#/volume] in Blood

18704

76333

1.43

255.85

12.4

10.3

0.00

e9/l

0.01

15819

60169

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1689

3244

2.73

255.85

1.4

1.3

483.83

574.86

mg/l

3.25

1624

3122

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2120

4589

2.43

254.51

3.0

2.8

24.50

24.83

mmol/l

3.19

2090

4492

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2326

5260

2.33

254.29

2.0

1.8

1.72

2.54

ug/l

2.11

2032

4683

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1072

1552

3.59

253.21

1.2

1.1

9.64

20.94

u/ml

0.99

(3009214) Lutropin [Units/volume] in Serum or Plasma

2307

5227

2.32

251.08

1.6

1.3

8.77

9.03

u/l

0.41

1838

4185

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1941

4084

2.49

246.82

2.0

1.6

1.19

1.20

g/l

0.96

1875

3942

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3303

8740

2.01

245.87

10.0

10.3

24.29

mmol/l

0.02

3214

8543

(3016502) Oxygen saturation in Arterial blood

4849

14588

1.78

245.86

9.0

8.2

95.46

95.54

0.31

4704

14049

(3027273) Bicarbonate [Moles/volume] in Venous blood

2554

6112

2.20

245.19

4.6

2.9

25.15

25.24

mmol/l

0.59

2490

5881

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1892

3954

2.51

243.84

2.0

1.6

0.23

0.24

g/l

1.99

1823

3801

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

778

895

4.50

243.63

2.0

2.3

20.80

18.87

nmol/l

4.37

708

860

(46235355) HIV 1 and 2 tests - Meaningful Use set

10147

37128

1.51

237.19

2.2

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1081

1669

3.37

233.16

2.2

1.7

4.16

2.77

titre

0.33

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1502

2853

2.75

231.85

1.3

1.2

3.78

3.70

mmol/l

1.56

1434

2706

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1132

1814

3.25

231.09

1.4

1.3

23.19

26.22

u/l

1.83

882

1533

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1687

3450

2.56

226.68

2.2

2.0

12.01

10.81

mg/l

5.16

1576

3282

(3044889) 12 lead EKG panel

26654

117260

1.40

226.26

4.3

3.5

1581.35

3346.43

0.27

165

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

814

1040

4.05

225.70

1.2

25.86

45.53

u/ml

1.07

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

716

821

4.51

224.98

1.3

1.2

87.87

61.57

u/ml

0.87

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6319

20933

1.63

224.87

2.4

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1951

4302

2.38

224.72

2.2

10.05

10.39

g/l

2.20

1717

3886

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

796

1009

4.09

222.82

1.9

1.5

—

(3000991) Gas panel - Venous blood

4460

13461

1.77

222.30

10.7

8.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2587

6505

2.10

219.33

2.5

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8370

29814

1.54

218.69

2.9

3.2

2.44

2.45

mmol/l

8.09

7520

26506

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8626

31046

1.52

214.35

1.9

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3601

10294

1.86

213.16

3.2

2.7

210.94

211.28

ng/l

0.01

3278

9368

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

926

1366

3.52

212.98

1.9

1.6

1956.00

5274.29

titre

0.71

(3035637) Corticotropin [Mass/volume] in Plasma

1031

1644

3.26

211.94

1.6

1.5

25.29

34.53

ng/l

3.47

1031

1638

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

739

919

4.16

211.62

1.9

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1918

4335

2.32

209.10

2.4

0.78

0.80

g/l

0.08

1683

3679

(3011288) Drugs identified in Urine by Screen method Nominal

2203

5291

2.19

208.87

4.5

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2158

5171

2.19

205.66

1.8

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1407

2755

2.66

205.17

1.6

1.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

1139

1981

2.99

204.30

3.6

2.9

1.51

1.59

0.24

989

1784

(3013139) Helicobacter pylori Ag [Presence] in Stool

3446

9862

1.85

202.83

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3196

8993

1.88

197.89

4.4

2.8

129.71

131.19

g/l

2.72

3118

8740

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6698

23162

1.56

197.06

2.5

2.0

—

(3038026) Centromere Ab [Units/volume] in Serum

619

702

4.55

196.84

1.3

1.2

42.01

44.50

u/ml

0.06

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8788

32250

1.49

196.69

1.7

22037545.02

34081897.22

pmol/l

1.27

7383

26733

(3023183) Ammonium ion [Moles/volume] in Plasma

1404

2820

2.59

195.00

3.3

2.3

33.15

34.83

umol/l

1.15

1270

2523

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5031

16282

1.65

193.57

2.8

2.1

12.61

13.39

nmol/l

8.11

4448

15002

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2187

5417

2.12

191.94

1.3

1.2

0.92

0.65

u/ml

0.51

198

480

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1219

2295

2.76

190.83

1.2

275.95

324.78

titre

0.25

183

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4586

14538

1.68

190.50

3.8

4.6

23.26

34.89

ug/l

0.86

3690

11691

(3024980) IgG subclass 4 [Mass/volume] in Serum

1166

2147

2.82

189.82

1.7

1.5

0.80

0.83

g/l

0.33

951

1542

(3026250) Tacrolimus [Mass/volume] in Blood

443

369

6.19

189.36

44.7

38.4

7.41

ug/l

0.01

402

338

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1220

2319

2.74

187.71

1.2

98.00

85.14

titre

0.14

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

839

1274

3.41

185.18

2.3

1.7

25.04

30.20

mg/l

1.56

285

491

(3007566) Smooth muscle Ab [Titer] in Serum

1754

4023

2.28

184.67

1.3

1.2

103.07

129.10

titre

0.68

150

435

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1448

3059

2.47

181.85

1.3

1.2

40.78

43.45

u/ml

0.09

(3034770) Mitochondria Ab [Titer] in Serum

1710

3926

2.27

179.55

1.3

1.2

747.95

1121.27

titre

1.11

102

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1358

2798

2.53

179.32

7.5

3.8

698.54

3617.52

iu/ml

0.67

224

285

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

431

371

5.98

179.17

2.5

2.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1014

1787

2.94

177.82

5.9

4.8

369.06

359.06

umol/l

1.11

879

1537

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2593

7071

1.93

175.38

2.8

2.2

5603.70

6788.82

u/l

1.03

987

2867

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1937

4744

2.14

174.50

1.6

19.38

2.32

iu/ml

0.71

301

858

(3002179) Metamyelocytes/Leukocytes in Blood

4030

12652

1.69

172.46

5.0

3.8

0.70

0.72

0.19

1484

3344

(3017181) Myelocytes/Leukocytes in Blood

4178

13256

1.67

171.92

5.2

3.9

0.88

0.99

1.34

1493

3651

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

16605

69556

1.35

170.17

4.5

3.1

0.27

0.40

estimate

0.32

3434

16386

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13769

56036

1.37

169.32

5.5

4.9

2.72

3.12

ug/l

1.24

12421

50799

(3005570) Glucose [Moles/volume] in Urine

668

917

3.76

169.16

1.9

1.7

72.54

8.13

mmol/l

—

(3026782) Osmolality of Urine

8268

30765

1.46

168.97

3.5

2.5

530.59

547.31

mosm/kgh2o

8.52

7394

26719

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

542

627

4.46

168.63

3.3

2.2

222.17

239.26

e6/l

0.77

460

509

(3008037) Lactate [Moles/volume] in Venous blood

1417

3076

2.40

168.05

3.9

2.7

1.52

1.66

mmol/l

4.27

1386

2992

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2094

5375

2.04

167.19

1.6

1.7

14.09

16.23

u/ml

0.72

419

1708

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2742

7741

1.86

167.08

3.8

2.6

1.30

1.27

0.68

2727

7705

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1393

3020

2.40

165.64

1.3

1.2

39.80

48.92

u/ml

0.85

108

280

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1358

2910

2.43

165.46

1.5

1.3

20.82

23.37

u/ml

0.22

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2716

7682

1.86

164.47

3.8

2.6

0.64

0.62

2.43

2703

7660

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

612

805

3.92

163.65

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

612

805

3.92

163.65

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

612

805

3.92

163.65

1.8

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1379

3000

2.39

162.75

1.5

1.4

3714.42

1024.00

e6/l

0.51

1125

2271

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1360

2941

2.41

162.55

1.6

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

4016

12792

1.66

162.32

5.2

3.9

0.09

0.14

3.27

1345

3197

(3048929) Epstein Barr virus Ab [Presence] in Serum

2119

5541

2.00

160.85

1.3

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1761

4301

2.14

159.49

3.4

3.2

38.18

44.19

mg/l

0.82

1599

3322

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4279

13918

1.63

159.40

9.9

8.6

122.02

122.38

g/l

0.49

4203

13550

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

530

633

4.32

159.07

3.2

2.2

0.67

0.65

e9/l

0.27

511

596

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2887

8415

1.81

158.86

1.1

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3744

11768

1.68

158.85

1.3

1.2

129.88

148.97

u/ml

1.88

1264

4672

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1362

2982

2.38

158.53

1.5

1.4

14.56

36.95

e6/l

2.21

1045

2102

(3034860) Kappa light chains.free [Mass/volume] in Serum

1760

4318

2.13

157.60

3.4

3.2

50.11

60.11

mg/l

0.65

1607

3339

(3014271) Vancomycin [Susceptibility]

422

410

5.30

157.20

3.1

2.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

405

381

5.47

155.53

1.5

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1593

3773

2.20

155.33

1.2

1.1

4.03

3.95

0.08

197

703

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

405

382

5.46

155.15

1.5

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1326

2896

2.38

155.13

1.4

1.2

266.88

247.15

u/ml

1.42

829

1861

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

519

627

4.27

153.74

3.2

2.1

526.68

515.31

e6/l

0.14

422

471

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1749

4347

2.10

151.52

2.8

2.2

—

(3025159) Blasts/Leukocytes in Blood

3965

12826

1.64

150.42

5.4

4.0

0.33

0.24

0.31

1202

3105

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1601

3858

2.16

149.71

3.2

3.1

3.01

7.39

ratio

0.59

1115

1754

(3019420) Tryptase [Mass/volume] in Serum or Plasma

459

511

4.63

148.95

1.7

1.6

7.89

7.88

ug/l

0.00

432

449

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

953

1795

2.75

148.87

1.4

1.3

0.17

0.30

nmol/l

1.18

120

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2296

6347

1.89

148.56

2.1

1.7

39.18

40.14

nmol/l

1.03

2197

6272

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1058

2123

2.58

146.92

3.8

2.1

892.02

3579.75

u/ml

1.83

114

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1540

3694

2.17

145.57

2.3

2.2

0.00

g/l

0.07

1378

3226

(3036489) Thrombin time

2137

5809

1.92

145.18

2.6

1.9

20.85

20.92

0.17

1886

5124

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

782

1339

3.02

143.69

1.1

3.06

7.64

au/ml

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

642

966

3.43

143.52

3.5

2.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1456

3453

2.19

141.38

2.3

0.00

g/l

-0.00

1376

3220

(3021387) Prolactin [Units/volume] in Serum or Plasma

2381

6778

1.84

140.71

1.8

1.6

320.88

286.32

mu/l

3.75

2165

6042

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

419

453

4.76

140.28

2.0

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

419

453

4.76

140.28

2.0

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

419

453

4.76

140.28

2.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

419

453

4.76

140.28

2.0

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1564

3833

2.12

140.20

2.3

2.2

0.03

0.02

g/l

0.75

1438

3387

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3159

9793

1.70

140.18

11.2

9.9

1.37

1.30

3.77

3136

9736

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2492

7216

1.81

139.50

1.1

15.06

4.67

u/ml

0.59

(3025941) Bacteria identified in Stool by Culture

2871

8675

1.74

139.46

1.3

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3082

9504

1.71

139.36

11.4

10.2

0.64

0.63

0.77

3058

9458

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

338

294

5.91

139.31

2.2

1.8

40.15

41.03

g/l

1.18

338

294

(3024666) Lithium [Moles/volume] in Serum or Plasma

497

631

4.06

138.84

13.9

13.0

0.62

0.61

mmol/l

0.10

454

571

(3044927) Protein electrophoresis panel - Urine

613

914

3.46

138.82

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2058

5607

1.92

138.76

5.0

4.4

1.61

1.65

0.71

1979

5243

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

757

1299

3.01

138.61

1.1

64.29

63.22

au/ml

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

824

1488

2.86

138.57

1.4

1.3

—

nmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

926

1790

2.68

137.95

1.4

1.3

0.58

3.19

nmol/l

1.29

911

1719

(40760892) CBC W Ordered Manual Differential panel - Blood

10011

39758

1.37

137.06

5.4

4.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3150

9845

1.68

135.50

11.3

10.1

94.15

93.81

2.46

3138

9813

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

848

1578

2.78

135.33

7.1

5.4

11.32

11.44

mg/l

0.27

788

1447

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

478

605

4.07

134.04

1.4

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

631

992

3.28

132.36

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

1217

2760

2.29

130.94

4.1

2.8

7.41

7.76

mmol/l

3.03

1191

2688

(3010375) cycloSPORINE [Mass/volume] in Blood

371

386

4.94

129.26

30.9

25.7

109.60

126.93

ug/l

2.27

300

335

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

467

598

4.02

129.13

1.4

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

622

989

3.24

128.29

1.2

1.1

37.34

47.61

mg/l

4.64

561

803

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1765

4690

1.96

127.63

2.2

1.8

200.54

207.52

pmol/l

1.70

1695

4497

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1227

2835

2.25

126.52

3.2

1.6

0.89

0.85

nmol/l

0.95

969

2508

(3029937) Albumin [Presence] in Urine by Test strip

11884

48933

1.33

126.46

4.7

3.3

0.00

estimate

0.95

3736

17672

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1202

2755

2.26

126.24

1.6

1.3

149.10

146.67

au/ml

0.26

359

821

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1103

2439

2.34

125.46

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

461

600

3.96

124.96

1.1

3.96

9.44

nmol/l

1.10

137

(4198724) Urine methamphetamine measurement

431

532

4.17

124.56

2.9

1.8

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

597

942

3.27

124.56

1.1

254.66

273.16

mg/l

0.92

555

820

(3027923) C peptide [Moles/volume] in Serum or Plasma

449

578

4.00

123.37

1.7

1.6

1.30

1.26

nmol/l

0.21

281

478

(3011412) CD3 cells [#/volume] in Blood

642

1070

3.10

123.17

3.0

2.1

1282.79

1119.77

e6/l

3.22

551

945

(3010838) Calcium [Moles/time] in 24 hour Urine

1026

2214

2.40

122.96

2.0

4.90

5.38

mmol/24h

3.70

901

2026

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

812

1563

2.69

121.89

2.5

2.4

21.45

28.43

iu/ml

0.84

118

(3016244) Insulin [Units/volume] in Serum or Plasma

517

751

3.55

121.43

3.4

3.0

25.53

27.22

mu/l

0.39

466

720

(3020961) Endomysium IgA Ab [Titer] in Serum

2514

7611

1.73

120.76

1.2

1.1

178.06

228.00

titre

0.48

247

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

684

1207

2.92

119.60

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1689

4533

1.94

118.61

3.2

2.2

182.38

191.67

3.64

1621

4324

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1752

4763

1.92

118.55

3.3

2.3

3.49

3.69

g/l

6.07

1694

4566

(3028192) IgG subclass 2 [Mass/volume] in Serum

714

1300

2.84

118.37

1.5

1.3

2.89

3.00

g/l

0.72

554

801

(3027135) IgG subclass 1 [Mass/volume] in Serum

714

1301

2.83

118.21

1.5

1.3

6.81

6.92

g/l

0.26

554

801

(3024139) IgG subclass 3 [Mass/volume] in Serum

713

1300

2.83

117.92

1.5

1.3

0.38

0.42

g/l

1.77

558

798

(3020191) Ethanol [Moles/volume] in Serum or Plasma

652

1134

2.97

116.79

1.6

1.3

1.37

1.28

promille

0.65

510

875

(4062490) Immunoglobulin typing, IgG

705

1287

2.83

116.35

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

796

1555

2.64

116.25

1.3

0.19

0.21

nmol/l

0.44

644

1189

(3014765) Yersinia sp identified in Stool by Organism specific culture

1452

3720

2.03

115.87

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1452

3725

2.03

115.45

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

1835

5132

1.86

114.03

2.6

2.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1444

3715

2.02

113.93

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

565

918

3.17

112.80

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1685

4599

1.91

112.62

3.6

2.9

0.35

iu/ml

0.30

946

2397

(3000475) Leukocytes [#/volume] in Synovial fluid

1322

3319

2.07

111.22

1.6

15030.35

13708.86

e6/l

0.33

1003

2253

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1005

2257

2.30

110.43

1.3

36.79

27.85

u/l

1.18

867

1936

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1782

4995

1.86

109.92

2.9

2.0

93.89

92.69

1.29

1727

4801

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

481

726

3.41

107.12

3.0

3.8

142.00

181.01

nmol/l

0.50

476

717

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

661

1224

2.79

106.41

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

411

563

3.76

104.47

1.4

1.2

—

(3003181) Sodium [Moles/volume] in Urine

1002

2304

2.25

104.37

1.5

1.4

61.57

61.60

mmol/l

0.01

768

1797

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

616

1111

2.86

103.83

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

260

235

5.68

103.70

3.8

2.9

1.90

2.04

ratio

0.38

234

215

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

303

325

4.79

102.40

2.3

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

303

325

4.79

102.40

2.3

1.9

—

(3042733) HLA Ab [Presence] in Serum

299

318

4.83

101.95

5.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

602

1083

2.87

101.91

1.2

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

590

1050

2.90

101.74

2.6

2.0

40.10

38.13

1.94

572

1036

(3007930) Methemoglobin/Hemoglobin.total in Blood

1820

5271

1.80

101.12

5.2

4.5

0.83

0.89

9.58

1753

4915

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

872

1911

2.36

101.07

1.1

1.48

1.51

g/l

1.57

786

1770

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

980

2264

2.24

100.98

1.1

0.48

4.25

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1104

2682

2.13

100.88

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

303

330

4.72

100.79

2.3

1.9

—

(40768443) Skin Pathology biopsy report

2211

6796

1.70

100.15

1.3

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

743

1518

2.53

99.54

2.3

2.6

1.29

1.30

g/24h

0.03

402

955

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

560

981

2.94

99.16

1.4

1.2

1.97

2.17

mmol/l

2.34

521

911

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

593

1076

2.84

98.93

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

592

1076

2.84

98.47

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

688

1359

2.61

98.41

3.3

3.5

6.90

13.44

nmol/l

0.57

675

1322

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

705

1411

2.58

98.33

1.3

1.2

28.08

26.18

nmol/l

0.12

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

995

2343

2.20

98.04

1.3

1.2

3.49

3.80

u/ml

0.46

466

1110

(3020891) Body temperature

2132

6542

1.70

97.10

5.2

4.3

36.92

36.90

°c

2.37

2115

6464

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

197

138

7.32

96.57

1.4

1.2

1.18

mmol/l

0.25

197

138

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

490

809

3.12

95.48

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

496

827

3.09

95.17

1.2

—

(3037756) Immunofixation for Serum or Plasma

1044

2542

2.12

94.84

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

572

1042

2.83

94.79

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

622

1194

2.69

93.87

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

341

446

3.93

91.99

1.1

7.52

8.09

u/ml

0.09

(3048879) Bone marrow aspiration report

225

201

5.74

90.74

2.0

1.6

2.00

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

435

692

3.23

89.76

2.8

2.9

901.69

1040.85

u/ml

0.38

427

685

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

545

999

2.81

89.36

1.1

282.72

284.96

mg/l

0.26

487

920

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1316

3571

1.91

89.26

1.8

1.4

—

(3024932) HLA-DR beta [Type]

269

294

4.70

89.20

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

356

498

3.67

88.10

2.3

1.5

1.93

2.00

umol/l

0.73

325

444

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1490

4234

1.83

87.83

2.0

7.74

8.19

iu/l

0.03

582

1785

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

417

659

3.25

86.92

1.4

6.45

5.93

u/l

0.38

360

571

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

366

529

3.56

86.68

3.0

1.6

140.40

110.73

umol/l

0.82

176

251

(3024471) HLA-A [Type]

270

305

4.54

86.43

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

711

1524

2.41

86.41

2.5

2.1

105.75

105.52

mmol/l

0.53

706

1508

(3041354) Potassium [Moles/volume] in Venous blood

711

1524

2.41

86.41

2.5

2.1

4.04

4.07

mmol/l

0.96

706

1509

(3014148) Varicella zoster virus Ab [Titer] in Serum

914

2190

2.16

86.36

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1325

3647

1.88

86.14

1.8

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1639

4828

1.76

85.90

4.7

2.8

1.50

1.46

mg/l

1.40

1496

4404

(3018405) Lactate [Moles/volume] in Arterial blood

1507

4331

1.81

85.67

4.4

3.9

1.39

1.46

mmol/l

1.31

1472

4254

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

447

747

3.08

85.50

2.5

1.6

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

197

162

6.24

85.33

1.1

—

(40761536) Microorganisms panel - Urine sediment

2308

17866

0.64

85.26

4.7

3.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1194

3193

1.94

84.45

1.5

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

1252

3416

1.90

83.53

5.0

3.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

398

630

3.25

82.78

1.8

1.3

20.36

26.96

umol/l

3.47

370

571

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

213

199

5.49

82.53

2.2

2.0

16.91

16.80

umol/l

0.04

213

199

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1415

4049

1.81

81.53

1.1

7.65

4.78

eliau/ml

0.60

140

676

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

143

9.16

81.37

7.3

8.3

62.74

71.46

1.49

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3222

11365

1.48

81.28

10.0

7.4

24.93

24.72

mmol/l

2.37

3210

11262

(3033705) Calcium.ionized [Moles/volume] in Venous blood

695

1520

2.36

80.94

2.6

2.1

1.20

mmol/l

0.02

690

1505

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

497

917

2.79

80.60

23.5

18.4

3298.45

3038.81

nmol/l

0.04

484

890

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

270

325

4.26

80.52

2.2

1.4

1149.76

3881.03

u/ml

1.32

(3047007) Chlamydophila sp Ab [Presence] in Serum

903

2217

2.10

80.33

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

981

2495

2.03

79.66

1.3

1.2

3.21

3.53

u/ml

0.19

373

960

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

479

873

2.82

79.38

17.1

13.4

821.57

1973.12

nmol/l

0.51

470

844

(3045716) Anion gap in Serum or Plasma by calculation

506

952

2.74

79.27

3.2

10.18

11.48

mmol/l

8.93

493

944

(21494755) Public health laboratory ask at order entry panel

3308

23560

0.69

79.13

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1406

4057

1.80

78.84

3.6

3.1

8.48

8.27

kpa

3.93

1371

3954

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1607

4828

1.73

78.64

2.1

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1008

2606

2.00

78.33

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

851

2064

2.13

78.05

1.1

3.48

2.71

0.64

126

425

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

541

1070

2.60

77.26

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

5489

21483

1.35

76.62

2.0

1.7

—

(21494434) Karyotype in Bone marrow

495

938

2.72

76.56

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

845

2060

2.12

76.52

1.6

1.5

74.16

68.15

mu/l

0.19

747

1852

(44806118) Parainfluenza type 4 nucleic acid detection

683

1524

2.31

76.15

1.6

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

471

871

2.78

76.11

2.4

1.8

13.97

15.51

2.19

456

853

(44790049) Parainfluenza type 3 nucleic acid detection

683

1525

2.31

76.04

1.6

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

683

1526

2.31

75.93

1.6

1.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

707

1605

2.27

75.84

1.1

1.92

2.02

iu/ml

0.04

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

332

493

3.46

75.80

1.1

531.01

347.14

ng/l

0.26

149

(44790047) Parainfluenza type 1 nucleic acid detection

683

1528

2.30

75.71

1.6

1.3

—

(3008295) Osmolality of Serum or Plasma

664

1467

2.33

75.66

1.7

1.4

280.92

278.62

mosm/kgh2o

1.26

481

1136

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

406

690

3.02

75.66

1.0

309.54

338.13

ng/l

0.88

262

549

(1175426) CD3 cells/Lymphocytes in Blood

484

912

2.73

75.63

2.4

1.9

73.21

72.54

0.36

462

884

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1506

4496

1.74

75.31

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

730

1686

2.23

75.28

1.3

1.2

63.19

54.47

u/ml

0.27

100

(3043409) Potassium [Moles/volume] in Arterial blood

1279

3636

1.82

75.21

4.7

4.2

3.86

3.91

mmol/l

2.97

1263

3607

(3008898) HLA-B27 [Presence]

1838

5801

1.65

75.01

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

405

694

3.00

74.48

1.0

40.24

41.92

ng/l

0.27

257

546

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

32568

156467

1.24

74.14

25.8

14.8

332.54

333.10

g/l

21.65

32403

155394

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

34.55

74.07

1.0

0.03

0.15

u/ml

0.45

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

403

694

2.98

73.52

1.0

767.52

728.69

ng/l

0.69

252

525

(3018333) Ribosomal P Ab [Presence] in Serum

523

1045

2.58

73.27

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

179

158

5.81

73.05

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

992

2624

1.95

72.35

1.2

1.1

2356.03

828.33

iu/ml

0.47

219

506

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

355

570

3.20

72.33

3.1

2.4

39.07

39.41

0.09

175

283

(3003888) Timothy IgE Ab [Units/volume] in Serum

1207

3420

1.83

71.71

1.1

5.00

5.63

u/ml

0.65

750

1706

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

422

761

2.85

71.28

3.0

1.7

96.60

97.46

0.17

411

713

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

302

440

3.52

70.84

2.0

2.6

0.96

1.14

ug/l

0.66

280

416

(4268621) Lupus anticoagulant assay

714

1677

2.19

70.80

2.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

449

842

2.74

70.80

1.4

1.2

5.27

5.63

umol/l

0.93

397

760

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

920

2390

1.99

70.56

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1807

5767

1.63

70.55

1.3

208.95

227.22

miu/ml

1.22

769

2821

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1885

6082

1.61

70.45

1.4

—

(4195642) Thrombophilia screening test

871

2228

2.02

69.66

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

424

778

2.80

69.50

1.2

1.3

0.57

0.68

ratio

3.38

281

368

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3115

11269

1.44

68.61

2.2

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

391

691

2.91

68.37

1.1

1.06

1.14

u/l

0.64

158

302

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1332

3948

1.75

68.23

1.1

1.81

2.42

u/ml

1.26

818

1919

(3026389) Candida sp identified in Specimen by Organism specific culture

766

1883

2.10

67.95

1.5

1.2

—

(3002256) Pathology report gross observation

5650

22598

1.32

67.27

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

403

732

2.83

67.26

1.7

1.4

1810890.32

1694031.29

iu/ml

0.07

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

496

1009

2.53

67.13

1.3

1.2

83.31

80.63

0.40

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

992

2701

1.90

66.56

1.1

16.68

14.56

au/ml

0.39

240

900

(3010503) CD19 cells [#/volume] in Blood

396

717

2.84

66.46

3.2

2.2

245.38

183.85

e6/l

0.31

380

701

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

489

994

2.53

66.29

1.7

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

872

2277

1.98

65.95

1.1

116.84

117.04

0.06

804

2057

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

149

121

6.31

65.32

2.2

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2642

9344

1.47

65.27

1.5

1.3

22.44

26.40

iu/l

7.87

2239

7859

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

157

136

5.92

65.18

2.1

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

589

1325

2.29

64.55

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

268

385

3.57

64.15

1.5

1.4

14.74

14.92

pmol/l

0.13

214

334

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

317

513

3.17

63.88

2.4

1.4

27.35

29.06

umol/l

1.93

302

468

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

264

377

3.59

63.71

2.7

1.7

30.56

29.22

0.61

250

360

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

363

644

2.90

63.10

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

939

2557

1.90

62.98

1.9

1.5

—

(3045142) Bone marrow Pathology biopsy report

618

1441

2.21

62.39

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3665

13875

1.38

62.19

2.4

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

551

1225

2.31

62.00

4.0

3.7

—

(3042517) Benzodiazepines panel - Urine

145

122

6.09

61.74

3.3

3.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1145

3346

1.77

61.51

1.1

0.92

1.12

u/ml

0.51

604

1350

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

367

666

2.83

61.39

1.3

1.2

65.29

112.33

titre

0.56

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1292

3922

1.70

60.84

1.5

1.4

—

(3033099) Centromere Ab [Titer] in Serum

193

223

4.44

60.42

1.1

—

(4015189) Microbial culture of sputum

188

213

4.52

60.15

2.2

2.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

757

1945

2.01

59.86

1.5

1.4

389.65

293.65

pmol/l

1.77

637

1681

(3024928) Oxygen saturation in Venous blood

1225

3692

1.71

59.17

4.4

2.7

63.17

61.74

1.28

1157

3582

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

337

596

2.90

58.93

2.1

1.8

151.42

151.61

0.01

322

567

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

457

954

2.46

58.80

1.2

1.1

1.13

3.30

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

372

699

2.73

58.55

1.3

1.2

564.58

650.98

titre

0.10

(4035726) Immunohistochemistry procedure

3660

13986

1.37

58.47

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

417

834

2.57

58.42

1.6

1.5

22.56

26.49

u/ml

0.76

166

(3006245) CD3-CD19+ cells/cells in Blood

270

419

3.31

58.00

2.7

2.0

9.96

9.72

0.09

253

396

(3004716) Salmonella sp identified in Stool by Organism specific culture

2344

8284

1.47

57.95

1.4

—

(40768446) Kidney Pathology biopsy report

305

516

3.03

57.39

1.8

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1046

3042

1.78

57.11

1.6

1.4

0.34

0.42

nmol/l

1.43

801

2392

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

264

409

3.31

56.86

3.3

2.3

0.60

0.61

mmol/l

1.10

264

409

(3028433) Virus identified in Specimen by Culture

224

310

3.71

56.43

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

520

1179

2.27

56.05

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1458

4672

1.61

55.89

1.5

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

416

852

2.51

55.65

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

575

1368

2.16

55.38

1.3

1.2

65.73

68.75

u/l

0.26

519

1183

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

676

1723

2.02

54.65

1.1

97.64

97.62

0.01

635

1623

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

332

611

2.79

54.26

1.9

1.5

12.13

4.81

nmol/l

0.49

271

503

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

372

729

2.62

54.22

1.1

—

(3003694) ABO and Rh group [Type] in Blood

12344

55148

1.20

53.81

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

309

549

2.89

53.67

2.6

2.5

159.24

144.40

nmol/l

1.03

285

452

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

347

659

2.70

53.62

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

273

450

3.11

53.57

1.5

1.4

199.36

296.59

nmol/24h

0.42

273

450

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2379

8559

1.44

53.55

7.7

6.2

24.41

24.42

mmol/l

0.07

2284

8124

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

293

505

2.98

53.53

1.4

1.5

492.80

863.36

mu/l

0.93

278

485

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

297

517

2.95

53.39

1.4

1.5

73.20

72.92

0.10

282

497

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

419

882

2.44

53.05

2.5

1.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

334

625

2.74

53.01

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

215

303

3.64

52.91

2.4

1.5

36.77

33.29

u/l

0.11

199

274

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

206

283

3.73

52.44

1.2

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

10.75

52.41

3.6

2.2

2.10

2.23

mg/l

0.17

(3052851) Hemolysis interference index of Serum or Plasma

1320

4204

1.62

51.84

3.5

3.0

2.38

2.04

index

0.57

760

1994

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1565

5197

1.56

51.67

3.2

3.8

896.78

3363.61

u/ml

1.15

1350

4498

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

647

1667

2.00

50.84

1.1

1.0

—

(3023410) Appearance of Cerebral spinal fluid

587

1460

2.07

50.64

1.8

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

207

294

3.61

50.44

1.2

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

937

2738

1.76

50.37

1.5

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

136

134

5.20

50.30

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

218

323

3.46

50.13

2.8

1.7

0.50

1.54

e9/l

0.50

115

131

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

445

990

2.31

50.10

1.1

—

0.22

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

268

456

3.01

50.04

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1086

3322

1.69

49.73

1.5

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

336

654

2.64

49.66

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

159

185

4.40

49.49

1.3

128.97

64.28

mu/l

0.67

111

144

(3001556) Androgen free Index in Serum or Plasma

126

117

5.52

49.29

1.4

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

863

2478

1.79

49.16

3.2

3.1

0.81

nmol/l

0.15

634

2034

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10210

45120

1.20

49.11

4.2

4.1

21.95

21.98

0.07

4884

20736

(3037692) Legionella sp identified in Specimen by Organism specific culture

221

336

3.37

49.00

1.5

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1031

3124

1.70

48.87

2.1

2.4

139.37

112.86

ug/min

0.67

594

1853

(43055514) Macroprolactin [Presence] in Serum or Plasma

233

370

3.23

48.47

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

326

636

2.63

47.99

1.3

1.2

169.39

167.55

mmol/24h

0.11

326

636

(40757494) Bilirubin.total [Moles/volume] in Blood

294

542

2.78

47.98

2.2

2.0

39.32

51.12

umol/l

0.31

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

134

137

5.01

47.82

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2320

8492

1.42

47.44

12.0

9.6

16.05

16.23

2.00

2255

8160

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

427

956

2.29

47.43

1.8

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

135

142

4.87

46.83

1.7

1.3

5487.86

15662.50

u/ml

0.43

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

460

1079

2.19

45.93

1.3

1.2

108.51

112.54

pmol/l

0.71

460

1079

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

173

231

3.84

45.75

1.6

1.5

0.44

0.42

ug/l

0.22

120

174

(3042111) Morphology [Interpretation] in Bone marrow Narrative

753

2129

1.82

45.10

1.7

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1073

3368

1.64

44.61

1.1

1.35

2.00

u/ml

2.25

668

1508

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

448

1056

2.18

44.23

1.4

1.2

1.98

2.82

u/ml

0.67

317

483

(3034426) Prothrombin time (PT)

239

412

2.97

43.77

1.3

1.2

28.60

27.67

1.45

239

412

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

309

616

2.57

43.71

1.1

0.13

0.70

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

167

227

3.77

43.20

1.3

1.2

373.50

324.35

pmol/l

0.19

112

176

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

228

385

3.04

43.18

1.3

1.2

0.30

0.31

g/l

0.38

201

292

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

253

457

2.84

42.85

2.1

1.8

175.25

169.22

0.29

245

426

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

133

151

4.51

42.61

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

956

2952

1.67

42.31

2.9

4.2

548.72

1191.07

u/ml

1.25

856

2694

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

441

1053

2.15

42.23

2.0

1.7

3.60

3.76

mg/l

0.31

419

999

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7847

34240

1.21

42.12

3.1

3.0

0.74

0.80

ug/l

2.71

5144

20545

(3016038) Potassium [Moles/volume] in Urine

378

847

2.29

41.98

1.4

1.2

34.07

34.83

mmol/l

0.23

320

749

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

649

1792

1.86

41.87

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

389

884

2.26

41.86

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

845

2532

1.72

41.72

1.2

0.88

1.29

0.58

154

(3017817) Protein [Mass] in Urine collected for unspecified duration

451

1093

2.12

41.65

2.8

2.4

1225.93

1115.64

0.40

446

1078

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

352

768

2.35

41.46

1.3

1.2

93.53

89.76

u/l

0.21

304

653

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

544

1426

1.96

40.86

1.3

40.05

41.56

u/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

464

1153

2.07

40.24

1.2

155.22

204.85

titre

0.57

167

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

463

1150

2.07

40.20

1.2

212.00

161.56

titre

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

763

2245

1.75

40.14

1.3

8.21

12.73

u/ml

0.47

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

36.40

40.02

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

156

214

3.73

39.92

1.1

1.4

3.72

2.62

u/ml

0.13

156

208

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

211

357

3.03

39.88

1.3

1.2

110.93

110.30

0.10

197

321

(3006270) Folate [Moles/volume] in Blood

436

1062

2.11

39.79

1.2

1.1

341.28

394.28

nmol/l

4.85

353

905

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

298

3.23

39.32

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.81

39.29

5.2

5.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

339

748

2.33

39.00

1.3

1.2

21.82

25.49

u/l

0.77

291

627

(21494890) Protein electrophoresis panel - 24 hour Urine

488

1255

2.00

38.67

2.3

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1796

6510

1.43

38.65

1.8

1.6

4.49

3.93

mg/l

1.04

1426

4490

(3010144) Erythrocytes [#/volume] in Synovial fluid

480

1229

2.01

38.49

1.4

154616.34

95180.63

e6/l

0.95

322

814

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

492

1278

1.98

37.94

1.4

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

128

157

4.17

37.63

1.6

1.2

683.45

100.78

ng/l

0.47

106

(4094501) Cardiovascular stress test using bicycle ergometer

1251

4246

1.52

37.44

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

998

3218

1.60

37.33

1.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

151

213

3.63

37.28

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

998

3219

1.60

37.28

1.4

1.2

—

(3017704) Immunofixation for Urine

270

547

2.53

37.11

1.8

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

424

1051

2.07

37.05

1.5

1.4

12.58

12.37

umol/l

0.22

396

997

(40768441) Liver Pathology biopsy report

421

1041

2.08

37.02

1.7

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

227

420

2.77

36.95

1.9

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

141

191

3.78

36.72

1.2

1.1

39.44

28.77

iu/ml

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

820

2527

1.67

36.61

2.2

9.00

6.17

umol/l

1.47

579

1853

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

102

106

4.93

35.93

1.2

1.3

48.17

54.43

0.40

(42529582) MDA5 Ab [Presence] in Serum by Line blot

184

306

3.08

35.80

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

184

306

3.08

35.80

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

184

306

3.08

35.80

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

184

306

3.08

35.80

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

121

148

4.19

35.72

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

6.40

35.68

1.0

0.54

0.34

u/ml

0.16

(3036670) Protein [Mass/volume] in Synovial fluid

189

321

3.02

35.57

1.3

1.2

40.24

40.96

g/l

0.22

102

165

(3021788) Differential panel - Synovial fluid

926

2970

1.61

35.41

1.5

1.00

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

154

229

3.44

35.40

1.3

1.1

—

(3023419) Bacteria identified in Sputum by Culture

590

1675

1.81

34.99

3.1

2.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

228

437

2.67

34.86

1.0

12.02

10.48

u/ml

0.36

127

319

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

631

1831

1.77

34.85

2.0

1.9

22.19

27.97

ug/l

2.26

614

1806

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

476

1261

1.94

34.79

5.0

5.7

109.49

82.10

u/ml

0.34

139

491

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

147

215

3.50

34.59

1.1

1.3

5.24

13.75

u/ml

0.90

136

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.79

34.59

2.7

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

230

446

2.64

34.42

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

117

145

4.13

34.03

1.5

1.7

61231.01

479040.07

nmol/l

1.31

124

(3033923) Metanephrine [Moles/time] in 24 hour Urine

135

188

3.68

33.95

1.1

0.74

0.96

umol/24h

0.28

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

115

143

4.12

33.33

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

378

937

2.07

33.10

1.1

1.2

1.06

1.07

ratio

1.40

329

760

(40765096) Chromosome analysis panel by Banding

181

316

2.93

32.61

1.1

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

221

432

2.62

32.61

1.2

112.21

105.31

1.40

211

394

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

582

1684

1.78

32.49

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

139

205

3.47

32.37

2.5

2.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

290

651

2.28

32.22

2.6

2.5

98.47

172.01

ug/l

0.25

279

621

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

217

425

2.62

31.92

1.4

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

215

420

2.62

31.78

1.2

90.40

90.52

0.01

106

200

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

267

581

2.36

31.77

2.3

2.4

53.25

51.40

umol/l

0.39

235

501

(3036603) Volume of Urine

413

1078

1.97

31.53

1.6

2165.26

1964.11

2.90

397

1064

(44806071) Cardiolipin IgM antibody measurement

123

169

3.73

31.52

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

133

194

3.51

31.47

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

217

430

2.59

31.23

1.1

90.93

91.40

0.06

106

201

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

107

133

4.12

31.06

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

192

358

2.75

30.93

1.3

1.2

123.92

131.38

nmol/l

0.25

140

254

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

138

210

3.36

30.77

1.5

1.3

0.22

0.24

nmol/l

0.19

100

137

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

602

1791

1.73

30.60

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

120

166

3.70

30.50

1.9

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

106

133

4.08

30.44

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

478

1331

1.84

30.21

1.5

1.3

1.52

1.43

nmol/l

0.77

433

1210

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

748

2377

1.62

29.76

1.1

3.20

2.74

eliau/ml

0.40

289

1338

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

858

2833

1.56

29.12

1.4

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

29.09

1.1

0.0

0.04

—

u/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

269

612

2.25

29.06

7.2

3.7

1302.89

4203.24

mg/l

1.32

199

415

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

300

717

2.15

28.86

1.2

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

161

283

2.91

28.75

1.3

1.1

11.21

10.60

pmol/l

0.08

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

172

315

2.80

28.64

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

177

332

2.73

28.26

1.5

1.2

16.43

umol/l

0.00

156

279

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

4.58

28.22

1.0

1.2

1.20

6.65

u/ml

1.54

(3012494) Peanut IgE Ab [Units/volume] in Serum

182

347

2.69

28.21

1.1

2.77

7.76

u/ml

0.98

103

206

(3024263) Appearance of Synovial fluid

264

609

2.22

27.66

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

270

629

2.20

27.64

1.7

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

270

629

2.20

27.64

1.7

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2000

7806

1.32

27.25

3.0

3.5

56.39

57.32

u/ml

0.04

1924

7580

(3014133) Dog dander IgE Ab [Units/volume] in Serum

893

3021

1.52

27.22

1.1

4.72

4.16

u/ml

0.30

519

1401

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

31225

153536

1.13

26.98

24.0

15.0

13.63

13.50

50.88

30954

150806

(3010370) Gastrin [Moles/volume] in Serum or Plasma

118

177

3.41

26.93

2.3

1.6

45.15

53.26

pmol/l

0.32

106

153

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

778

2559

1.56

26.88

1.1

1.0

0.24

0.46

u/ml

1.14

329

622

(3011841) English Walnut IgE Ab [Units/volume] in Serum

103

4.32

26.78

1.0

1.2

1.21

11.56

u/ml

2.20

(3009015) Lactate [Moles/volume] in Synovial fluid

4.75

26.60

1.4

1.3

6.31

5.88

mmol/l

0.21

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

4.21

26.28

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

204

429

2.44

26.19

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

7.08

26.13

10.6

11.4

87.09

202.04

e6/l

1.27

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

369

992

1.91

26.01

1.6

1.3

12.65

12.51

u/l

0.14

356

966

(44813793) Dust mix specific IgE antibody measurement

391

1074

1.87

25.85

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

210

451

2.39

25.82

3.1

2.9

28.86

28.27

umol/l

0.26

147

346

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

6.16

25.61

2.0

1.2

157.12

227.47

ug/g

1.22

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

6.02

25.55

1.3

1.1

25.92

17.56

0.30

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.91

25.42

1.5

1.7

1.58

1.70

mg/l

0.07

(3043238) Trisomy 21 risk [Likelihood] in Fetus

738

5662

0.66

25.38

1.5

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

111

168

3.38

25.04

2.5

3.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

154

287

2.75

24.94

1.6

1.5

9.25

9.47

ug/l

0.19

154

287

(3016228) CD19 cells/cells in Blood

231

527

2.25

24.89

2.1

1.9

9.04

7.32

1.07

225

515

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1308

9044

0.73

24.85

1.1

0.65

0.63

ratio

0.60

167

1054

(3007463) Buprenorphine [Presence] in Urine

6.07

24.48

5.7

12.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

278

690

2.07

24.43

1.2

4.46

19.92

u/ml

1.21

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.90

24.34

1.5

1.7

2.37

1.80

mg/l

0.29

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.90

24.34

1.5

1.7

4.02

3.42

mg/l

0.22

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.90

24.34

1.5

1.7

0.65

0.57

mg/l

0.10

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.90

24.34

1.5

1.7

2.71

2.57

mg/l

0.06

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.90

24.34

1.5

1.7

1.57

1.73

mg/l

0.07

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.90

24.34

1.5

1.7

2.17

3.38

mg/l

0.61

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.90

24.34

1.5

1.7

1.08

1.38

mg/l

0.23

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

155

294

2.70

24.34

1.2

72.76

75.54

0.19

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

105

4.09

24.32

1.0

1.1

0.34

6.97

u/ml

0.62

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

108

165

3.35

24.06

2.4

1.9

1.22

1.52

mmol/l

0.63

127

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.84

24.01

1.5

1.7

1.16

2.19

mg/l

1.02

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.84

24.01

1.5

1.7

2.27

1.07

mg/l

1.12

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

4.25

23.94

1.0

1.1

3.05

0.39

u/ml

0.44

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

285

720

2.03

23.92

1.2

1.1

88.93

82.03

u/l

0.55

261

618

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

282

710

2.04

23.89

1.2

1.1

28.97

22.40

u/l

0.84

252

615

(3005033) Fetal Nuchal fold Thickness US

716

5458

0.66

23.85

1.5

1.22

1.26

1.33

559

3969

(3021901) Oxygen saturation in Capillary blood

960

3392

1.46

23.74

3.1

2.9

90.46

89.96

1.28

934

3301

(3041672) Baker's yeast Ab [Presence] in Serum

6.49

23.56

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

971

3447

1.45

23.44

1.7

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

675

2231

1.55

22.92

1.5

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

741

5557

0.68

22.69

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

409

1189

1.76

22.66

1.1

7.56

8.13

iu/ml

0.17

391

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

153

300

2.61

22.63

1.3

1.2

81.09

84.02

0.22

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

124

216

2.94

22.60

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

563

1788

1.62

22.59

1.6

1.5

56.27

56.89

0.12

393

1106

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

234

560

2.14

22.58

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

279

715

2.00

22.58

1.1

3.69

4.28

iu/ml

0.34

(21494814) CD8 cells/Lymphocytes in Specimen

229

544

2.16

22.50

2.2

1.9

30.10

32.08

0.98

229

544

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

5.39

22.46

1.0

2.96

3.06

u/ml

0.01

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

106

3.91

22.23

1.0

1.1

0.06

1.51

u/ml

0.82

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

131

3.55

22.07

1.2

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

3152

19292

0.82

22.03

1.7

1.6

3.46

3.51

mmol/l

1.34

2166

12967

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4280

25475

0.84

21.93

1.9

3.57

3.53

ratio

1.10

3302

19348

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

201

458

2.25

21.80

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

270

693

2.00

21.78

2.0

1.7

2.41

3.01

u/field

0.37

189

555

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

5.11

21.74

1.1

22.99

14.18

u/ml

0.94

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

5.11

21.74

1.1

22.70

20.23

u/ml

0.08

(3019174) dRVVT (LA screen)

3.97

21.25

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

232

568

2.09

21.19

1.5

1.6

2922.67

3407.40

titre

0.33

100

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

5.11

21.02

1.5

2.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

136

3.42

20.98

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5925

26612

1.16

20.93

1.6

1.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

9.20

20.73

3.6

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.92

20.65

1.1

2.13

1.66

iu/ml

1.17

(40762887) Creatinine [Moles/volume] in Blood

4.66

20.47

1.5

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

5.02

20.31

5.0

4.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1322

5074

1.34

20.22

1.2

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4.18

19.96

1.2

14.33

14.30

nmol/l

0.00

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

422

1285

1.68

19.95

1.1

18.21

20.54

u/ml

0.55

158

562

(3051611) Lipemic interference index of Serum or Plasma

452

1405

1.65

19.79

3.9

3.2

13.68

13.25

index

0.29

299

773

(3023430) Cat dander IgE Ab [Units/volume] in Serum

820

2914

1.45

19.76

1.1

5.21

5.54

u/ml

0.16

442

1227

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

282

762

1.90

19.73

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

292

799

1.87

19.68

1.6

1.5

7.19

6.32

u/l

0.47

250

588

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.21

19.53

2.2

1.6

47.55

44.86

umol/l

0.27

(3047181) Lactate [Moles/volume] in Blood

1065

3979

1.38

19.35

5.8

4.9

1.37

1.29

mmol/l

1.19

951

3408

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

126

3.41

19.31

1.1

—

(3051339) Copper [Moles/volume] in Blood

5.58

19.22

1.3

16.69

15.35

umol/l

0.79

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

7.47

19.17

3.5

3.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15195

72614

1.11

19.07

1.9

1.8

1.42

1.35

mmol/l

12.95

13127

60731

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

290

801

1.86

19.02

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

321

919

1.79

18.81

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

176

406

2.22

18.64

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

11179

52626

1.11

18.59

3.8

2.8

0.29

0.18

estimate

0.39

3314

15770

(3023199) Leukocytes [#/volume] in Pleural fluid

550

1824

1.55

18.51

1.5

1.4

2345.78

2966.58

e6/l

0.47

418

1223

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

390

1188

1.68

18.46

2.2

1.9

1.43

1.66

u/field

0.42

241

628

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

141

3.19

18.40

1.8

1.7

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

4.22

18.39

3.3

2.9

25.17

68.33

pmol/l

0.42

(3020393) Adenovirus Ag [Presence] in Stool

108

3.55

18.26

1.4

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

105

189

2.84

18.22

1.1

—

(4034850) Laboratory test

973

6707

0.74

18.15

12.5

8.3

—

(3018133) Calcium [Moles/volume] in Urine

118

228

2.65

18.06

2.0

1.6

2.75

2.78

mmol/l

0.04

103

212

(3028308) Erythrocytes [#/volume] in Pleural fluid

507

1662

1.57

17.96

1.5

1.4

58923.14

49271.65

e6/l

0.35

335

889

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

102

3.61

17.93

1.5

1.4

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

102

3.61

17.93

1.0

1.1

0.24

1.88

u/ml

1.31

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.11

17.84

1.1

0.70

0.40

iu/ml

1.16

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1235

4793

1.33

17.57

1.9

1.6

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

8.03

17.49

1.8

1.7

279.95

190.63

nmol/l

0.30

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

183

442

2.12

17.40

1.2

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

111

3.41

17.06

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

151

3.02

17.06

1.1

1.0

0.01

0.42

u/ml

0.99

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

4.21

16.90

1.0

1.2

0.27

1.38

u/ml

0.45

(3038177) Helicobacter pylori Ab [Presence] in Serum

778

2823

1.42

16.82

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

193

483

2.05

16.79

1.2

0.74

0.22

g/l

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

908

3389

1.38

16.66

1.6

1.4

141.66

144.52

pmol/l

0.05

883

3320

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

124

3.22

16.55

1.1

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

134

289

2.37

16.54

1.1

1.34

0.77

u/ml

0.64

108

275

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

182

448

2.08

16.53

1.3

11.71

22.60

1.03

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1028

3925

1.35

16.36

1.3

—

(3020491) Glucose [Moles/volume] in Blood

356

1095

1.67

16.33

1.7

1.9

6.65

6.73

mmol/l

0.14

217

886

(44806420) Estimation of glomerular filtration rate

293

2493

0.60

16.22

2.2

2.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

236

644

1.88

16.15

1.0

1.1

98.19

95.11

0.78

200

494

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

162

2.87

16.15

2.1

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

244

674

1.85

16.10

2.0

2.1

8.34

7.90

mmol/l

0.79

244

674

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.90

15.97

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

122

3.19

15.91

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

106

209

2.60

15.69

1.8

1.3

—

(3047189) Immunofixation for 24 hour Urine

221

596

1.90

15.68

1.7

1.8

—

(40763590) HLA-DQ beta [Type]

5.91

15.63

1.0

—

(40760410) HLA-B [Type] by High resolution

5.71

15.59

1.0

—

(46236302) HLA-C [Type] by High resolution typing

5.71

15.59

1.0

—

(40760409) HLA-A [Type] by High resolution

5.71

15.59

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

371

1173

1.62

15.34

1.2

1.1

—

(3013862) HLA-DP [Type]

5.73

15.23

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

6.82

15.14

2.6

2.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

163

2.79

15.08

1.1

1.3

34.10

47.72

mg/l

1.84

136

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

276

810

1.75

15.02

6.8

8.0

105.70

36.30

ug/l

0.57

180

567

(3036180) Methadone [Presence] in Urine

8.63

14.98

3.9

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

649

2329

1.43

14.98

4.4

3.6

30.99

43.62

u/ml

1.76

632

2242

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

2.91

14.92

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.25

14.83

1.4

1.3

—

(3014891) Appearance of Pleural fluid

154

2.82

14.68

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.37

14.61

1.0

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

231

650

1.82

14.45

1.3

77.58

67.38

0.75

(3044009) aPTT.lupus sensitive (LA screen)

114

3.14

14.38

1.3

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

592

2108

1.44

14.27

1.5

1.4

31.81

33.50

g/l

2.32

542

1924

(3001686) Cold agglutinin [Titer] in Serum or Plasma

101

205

2.52

14.19

1.3

1.2

80.09

555.52

titre

0.62

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

223

626

1.82

14.07

3.4

3.2

7.98

9.29

mg/l

1.78

185

482

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

234

672

1.78

13.74

1.2

1.3

1043.24

1075.17

titre

0.11

149

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

155

387

2.05

13.68

1.3

1.2

217.90

180.60

ug/l

0.09

201

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

573

2046

1.44

13.64

1.6

1.4

—

(3022229) Phosphate [Moles/volume] in Urine

4.13

13.63

2.0

1.6

19.89

21.90

mmol/l

0.18

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

3.56

13.55

1.3

0.98

1.31

ml/s/173m2

1.26

(3010015) Selenium [Moles/volume] in Serum or Plasma

119

3.01

13.48

2.6

1.5

1.36

1.31

umol/l

0.25

(40762814) Titanium [Mass/volume] in Blood

177

2.60

13.46

2.4

2.6

3.69

3.54

ug/l

0.08

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

395

3010

0.67

13.34

2.7

2.3

13.15

13.12

0.30

388

2966

(3013247) Albumin in CSF/Albumin in Serum or Plasma

139

336

2.12

13.33

1.1

6.64

6.34

mg/g

0.17

134

324

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.76

13.23

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

141

2.79

13.11

1.3

1.2

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

4.29

13.04

1.0

1.1

12.56

23.45

u/ml

0.44

(3043410) Blood group antigens tested for on Red Blood Cells

148

374

2.03

12.70

1.8

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

146

369

2.02

12.53

1.7

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3277

19094

0.87

12.38

3.6

3.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

4.33

12.25

1.2

1.1

0.82

0.42

umol/24h

0.34

(3017509) Phencyclidine [Presence] in Urine

196

2.43

12.19

2.3

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

408

1396

1.50

12.11

1.4

1.3

394.01

482.41

u/l

0.94

393

1326

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.60

12.06

1.5

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

193

545

1.81

12.04

2.7

2.4

147.88

143.83

au/ml

0.03

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

261

805

1.66

12.01

1.1

181.47

227.74

iu/ml

1.22

261

795

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

510

3632

0.71

11.87

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

238

721

1.69

11.72

7.0

4.8

783.29

1539.67

u/ml

0.29

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1041

4178

1.28

11.70

2.1

2.3

131.86

131.26

g/l

0.33

757

3383

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.51

11.64

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.26

11.35

5.8

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.03

11.34

1.2

1.89

1.69

umol/24h

0.49

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

789

3070

1.32

11.20

3.8

3.0

10.02

9.03

pmol/l

0.82

789

3065

(3002621) Streptococcal DNAse B [Units/volume] in Serum

122

2.77

11.12

1.0

1.1

404.60

322.03

u/ml

0.33

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

130

331

2.01

11.01

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

194

567

1.75

10.87

2.3

1.9

9.06

9.49

mg/l

0.49

170

446

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

124

2.72

10.82

2.3

3.0

0.55

0.48

u/field

0.20

124

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

447

1599

1.43

10.66

1.5

1.3

157.89

200.39

pmol/l

1.84

447

1599

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

109

263

2.12

10.61

1.8

1.5

5.16

6.01

nmol/l

1.49

104

256

(3017315) Amylase [Enzymatic activity/volume] in Urine

269

867

1.59

10.49

1.3

1.2

203.07

368.49

u/l

2.65

235

817

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

3.61

10.39

1.1

1.4

12.96

15.21

0.18

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

104

2.85

10.33

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

119

301

2.02

10.29

1.2

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

8.09

10.15

1.3

1.1

2.32

1.48

g/l

1.34

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

119

303

2.01

10.12

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

132

2.60

10.10

3.0

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

398

1409

1.45

10.06

2.3

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

173

501

1.77

10.04

2.7

1.6

4881.34

2533.86

e6/l

0.23

131

297

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

593

2250

1.35

10.03

1.6

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.29

10.02

1.5

1.6

33.44

19.39

nmol/l

0.77

(3017569) Oxygen content in Arterial blood

229

719

1.63

9.95

2.0

2.4

15.96

16.00

0.06

229

719

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

202

614

1.68

9.91

3.8

3.1

1.24

1.25

0.02

202

614

(3045462) Protein/Creatinine [Ratio] in Urine

165

2.39

9.84

3.9

6.4

59.52

49.47

mg/mmol

0.19

154

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

118

303

1.99

9.82

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.77

9.78

1.1

1.6

25.98

30.93

umol/24h

0.48

(3008116) Ketones [Moles/volume] in Urine by Test strip

115

294

2.00

9.69

1.8

1.2

0.33

0.35

mmol/l

0.04

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.36

9.64

1.1

1.4

43.15

35.44

0.42

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.85

9.48

1.0

1.1

5.58

8.04

u/ml

0.37

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.92

9.38

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.99

9.30

1.0

0.27

0.29

u/ml

0.05

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

165

2.32

9.10

3.4

2.6

69.41

73.58

pmol/l

0.09

148

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

5.11

8.98

1.0

0.25

0.89

u/ml

0.45

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

113

296

1.95

8.95

1.2

—

(3042631) Mycobacterium sp identified in Specimen

553

2115

1.34

8.94

3.0

2.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.58

8.80

1.5

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

146

420

1.78

8.73

1.9

1.7

101.61

133.87

au/ml

0.34

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

134

2.44

8.64

1.0

1.1

0.58

0.54

u/ml

0.05

(3026692) Albumin [Mass/volume] in Peritoneal fluid

133

374

1.82

8.57

1.5

1.2

14.67

13.26

g/l

0.85

107

282

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

580

2249

1.32

8.57

1.5

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

106

276

1.96

8.56

2.1

2.9

272.20

908.43

ug/l

0.61

106

276

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

219

708

1.58

8.54

1.2

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

657

4294

0.78

8.51

4.2

3.7

5.01

5.00

kpa

0.17

646

4196

(3012501) Base excess in Blood by calculation

657

4294

0.78

8.51

4.2

3.7

2.38

2.49

mmol/l

0.47

441

2882

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.07

8.49

2.2

2.1

0.69

0.61

ug/l

0.62

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

4.01

8.41

1.2

1.0

333.82

214.29

pmol/l

0.59

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

127

355

1.83

8.35

1.3

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.59

8.35

1.1

1.13

2.28

u/ml

0.42

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.18

8.23

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.90

8.15

2.0

2.4

299.93

211.53

ug/l

1.11

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.69

8.00

1.3

277.88

324.49

umol/24h

0.94

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.63

7.99

1.5

1.4

8.88

20.87

pmol/l

1.42

(40757373) Influenza virus identified in Isolate

206

2.09

7.98

1.7

1.4

—

(3033086) Enterovirus Ab [Titer] in Serum

4.15

7.87

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

327

1173

1.43

7.84

1.9

1.7

24.58

881.02

pmol/l

0.84

147

(3002331) Protein [Mass/volume] in Peritoneal fluid

116

322

1.84

7.82

1.6

1.2

27.83

99.95

g/l

0.69

252

(3027315) Oxygen [Partial pressure] in Blood

667

4304

0.79

7.81

4.3

3.7

8.88

8.64

kpa

2.56

656

4206

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

164

2.21

7.80

1.3

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

138

2.33

7.78

3.3

2.5

1.58

1.31

mg/l

0.23

(3028717) Thiamine [Mass/volume] in Blood

155

2.24

7.70

1.3

1.1

63.57

63.80

ug/l

0.03

155

(3042951) Complement C1q Ab [Units/volume] in Serum

3.37

7.70

1.2

11.90

26.53

u/ml

—

(3004775) Volume in Urine collected for unspecified duration

307

1094

1.44

7.64

2.4

2.0

667.29

697.52

0.59

233

677

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

3.28

7.62

1.0

1.3

1.40

0.94

0.32

(3026470) Cobalt [Mass/volume] in Blood

227

762

1.52

7.58

2.2

2.3

4.06

3.52

ug/l

0.29

209

709

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.57

7.55

9.8

8.3

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

5.40

7.49

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

313

1124

1.43

7.48

1.3

1.2

13.66

14.16

u/l

0.13

288

1053

(3045788) Cell count panel - Pleural fluid

410

1543

1.36

7.45

1.5

1.4

—

(40768800) Prostate Pathology biopsy report

827

3417

1.24

7.45

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

163

508

1.64

7.43

1.1

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

241

1.95

7.38

1.6

1.3

21.56

22.96

0.18

198

(3016031) Almond IgE Ab [Units/volume] in Serum

101

2.53

7.30

1.0

1.1

0.84

1.29

u/ml

0.39

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

147

450

1.67

7.18

2.6

1.5

24118.84

12882.30

e6/l

0.38

198

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.87

7.17

1.2

2.7

2.88

1.79

mu/l

0.42

(3020650) Glucose [Presence] in Urine

875

0.57

7.06

1.6

1.4

0.06

0.04

estimate

0.18

875

(3012898) Urea [Moles/volume] in Urine

136

2.26

6.92

1.3

1.4

171.30

171.74

mmol/l

0.01

115

(3025577) Chromium [Mass/volume] in Blood

221

755

1.50

6.85

2.1

2.3

2.34

2.30

ug/l

0.04

176

649

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.69

6.72

1.1

1.0

—

(4133840) Spirometry

142

439

1.65

6.72

1.2

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

3.00

6.69

2.1

1.5

0.62

0.76

umol/l

0.57

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1034

6275

0.84

6.67

1.7

1.6

—

(3049233) Organic acids panel - Urine

8.18

6.58

1.1

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

130

2.24

6.51

1.2

1.1

9.09

9.40

mg/l

0.09

122

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

220

1.93

6.50

2.3

3.2

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

4.62

6.49

1.1

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

4.62

6.49

1.1

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

154

2.12

6.46

3.4

2.9

37.57

46.07

umol/l

1.87

134

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.53

6.45

1.1

1.7

2.02

9.94

u/ml

0.56

(3000285) Sodium [Moles/volume] in Blood

239

1.88

6.43

1.3

1.2

138.79

138.67

mmol/l

0.10

203

(3029612) Listeria sp Ab [Titer] in Serum

5.11

6.40

1.4

1.2

—

(3006462) Nitrate [Presence] in Urine

198

672

1.51

6.37

4.4

2.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

4.13

6.35

1.7

1.2

1.39

2.35

mmol/24h

1.58

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.88

6.19

1.0

1.1

—

(4211845) Urine protein measurement

212

736

1.47

6.14

4.2

2.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.53

6.03

1.3

1.4

—

14.32

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.50

5.96

8.0

10.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1029

6181

0.85

5.93

1.4

1.5

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.81

5.89

2.4

1.8

201.56

191.37

ng/l

0.38

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.71

5.87

3.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.36

5.87

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

9.49

5.83

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

111

335

1.69

5.81

1.3

38.24

40.37

0.21

235

(40768806) Pleura Pathology biopsy report

431

1702

1.30

5.76

1.6

1.5

—

(40758292) HTLV I+II Ab panel - Serum

104

311

1.71

5.63

1.4

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.89

5.63

1.4

1.2

0.08

g/l

0.06

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.70

5.60

1.0

2.83

1.17

u/ml

0.38

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

229

823

1.42

5.59

1.8

1.75

3.52

u/ml

2.04

246

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2151

12231

0.89

5.57

1.6

986.60

1018.16

mu/l

0.73

1850

10377

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1109

6584

0.86

5.54

1.5

1.6

59.43

62.70

ug/l

1.52

985

5421

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1052

6269

0.85

5.52

1.5

1.13

1.18

ratio

0.94

694

3604

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1056

6288

0.85

5.49

1.5

0.94

ratio

0.07

697

3623

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1056

6288

0.85

5.49

1.5

1.17

1.18

ratio

0.18

698

3644

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

144

472

1.56

5.48

1.9

1.79

1.69

ratio

0.33

138

459

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

3.88

5.38

6.9

13.2

38.00

49.80

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

3.58

5.37

1.5

1.6

590.86

2323.00

umol/l

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.43

5.36

1.3

1.1

82.25

48.19

u/l

0.48

(3032641) Amino acids panel - Urine

4.79

5.32

1.1

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.60

5.16

1.1

2.25

4.43

u/l

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

100

2.25

5.15

4.0

2.1

10.74

16.86

0.83

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

162

1.96

5.14

1.6

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

162

1.96

5.14

3.1

2.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.73

5.14

1.2

1.1

3.42

2.58

0.38

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

128

2.08

5.05

1.3

1.2

0.06

0.34

u/ml

1.22

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.82

4.89

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

323

1259

1.31

4.83

1.1

1.40

2.09

u/ml

0.34

130

349

(3007919) Fasciola sp Ab [Titer] in Serum

3.68

4.79

1.0

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

10.22

4.73

1.1

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

171

1.88

4.72

12.1

6.9

0.37

0.30

umol/l

0.81

149

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.33

4.72

1.4

1.3

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

5.50

4.63

1.0

0.11

0.08

u/ml

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

3.16

4.56

1.0

0.12

0.06

u/ml

0.37

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

107

2.10

4.45

1.4

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.32

4.44

1.1

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.71

4.44

1.0

1.1

272.81

270.84

nmol/l

0.01

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.19

4.42

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

132

1.98

4.40

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

190

693

1.40

4.38

4.5

3.6

—

(3044007) Cell count panel - Peritoneal fluid

136

466

1.49

4.34

2.4

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

6.13

4.33

1.0

1.1

0.09

1.50

u/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.21

4.32

1.2

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.17

4.25

1.7

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

115

382

1.54

4.24

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

157

558

1.44

4.19

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.20

4.18

1.7

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

125

1.96

4.09

1.2

1.1

91.33

91.39

titre

0.00

125

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

101

2.08

4.04

1.1

9.95

12.00

u/l

0.26

101

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

115

2.00

4.04

1.1

1.0

—

(40768793) Breast Pathology biopsy report

843

3718

1.16

3.97

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

112

378

1.52

3.88

2.8

2.4

151.85

100.10

ng/l

0.80

186

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

110

2.00

3.87

1.5

1.2

56.18

48.81

mg/l

0.32

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

100

2.04

3.82

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

145

523

1.42

3.63

1.1

63.70

64.84

u/ml

0.06

145

511

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

4.72

3.63

1.3

1.1

1.47

1.38

mg/l

0.07

(3042301) Urate [Moles/volume] in Synovial fluid

3.58

3.63

1.1

1.0

416.40

353.18

umol/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

714

0.66

3.63

2.6

3.4

47.14

45.28

0.38

714

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

714

0.66

3.63

5.1

6.7

8.57

8.54

0.02

714

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.10

3.61

1.2

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.46

3.61

1.2

1.1

0.03

0.97

mg/l

0.52

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.20

3.55

1.1

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

501

3047

0.84

3.53

2.1

1.7

1.68

1.78

mmol/l

1.18

485

2967

(3027696) Helicobacter pylori Ab [Titer] in Serum

6.57

3.50

1.2

1.0

1177.78

1378.57

titre

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.00

3.46

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

384

1602

1.23

3.42

1.4

1.3

6.27

6.06

mmol/l

0.67

358

1494

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.30

3.42

1.9

1.5

0.20

0.35

u/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

718

4229

0.87

3.40

4.2

3.0

25.91

27.99

mg/l

0.87

477

2955

(3002619) Bacteria identified in Specimen by Culture

111

387

1.47

3.35

1.4

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.24

3.34

1.0

0.69

0.16

u/ml

0.52

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

154

1.76

3.33

1.2

1.1

21.03

20.73

u/l

0.03

102

(3002523) Influenza virus A Ag [Presence] in Specimen

873

3915

1.14

3.33

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

264

1701

0.79

3.33

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

193

1.67

3.30

1.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

233

1.60

3.28

1.6

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

304

1244

1.25

3.26

1.0

1.1

1.71

5.13

u/ml

0.50

100

284

(3003740) Influenza virus B Ag [Presence] in Specimen

871

3914

1.14

3.24

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.25

3.21

6.9

4.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

145

1.76

3.18

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.08

3.16

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

182

1.66

3.04

1.6

1.5

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

2.49

3.00

1.0

9542.50

9235.59

ng/l

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.16

3.00

1.4

553.96

433.01

nmol/l

0.43

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.09

2.98

6.6

3.4

103.41

105.28

g/l

0.28

(43055442) Apixaban [Mass/volume] in Serum or Plasma

219

1.59

2.98

1.6

86.12

112.76

ug/l

1.45

178

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

248

1.55

2.95

1.3

2.0

2.71

4.41

ug/l

0.41

168

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

204

808

1.29

2.89

1.3

1.4

5.73

5.54

mmol/l

1.33

188

763

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.98

2.81

1.1

0.05

4.09

u/ml

1.96

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.75

2.81

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.75

2.81

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.75

2.81

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.75

2.81

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.75

2.81

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.75

2.81

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.43

2.73

6.8

5.4

0.99

1.63

mg/l

0.84

(3007542) Rye IgE Ab [Units/volume] in Serum

1.96

2.73

1.0

0.73

0.24

u/ml

0.41

(1616796) Gas panel - Central venous blood

922

4216

1.12

2.66

3.7

3.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

176

1154

0.78

2.66

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

866

4949

0.89

2.65

1.6

1.5

56.81

61.03

ug/l

2.07

866

4949

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

218

1.55

2.64

1.0

83.80

77.76

ug/l

0.50

177

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.07

2.56

1.1

—

(3010421) pH of Blood

1079

6079

0.90

2.55

3.9

3.4

7.41

6.72

1068

5991

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

300

1264

1.21

2.54

1.2

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

156

1.64

2.53

1.3

1.2

648.54

67.59

u/l

0.52

110

(40765089) Chromosome analysis panel - Blood by G-banded

179

714

1.28

2.47

1.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

117

439

1.36

2.46

6.4

5.5

24.52

24.99

mmol/l

0.59

110

385

(3014178) Parietal cell Ab [Units/volume] in Serum

5.11

2.43

1.0

54.57

28.14

u/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

246

1535

0.82

2.42

1.5

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

115

432

1.36

2.41

1.4

1.2

3.37

3.73

mmol/l

0.61

104

399

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

6.13

2.38

1.0

265.67

281.60

nmol/l

—

(3022689) Creatine [Moles/volume] in Urine

109

408

1.37

2.35

1.4

1.3

8.11

8.98

mmol/l

1.05

109

408

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.95

2.32

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

247

1.47

2.29

1.1

1.0

—

(3024316) Viscosity of Plasma

1.92

2.29

1.9

2.0

1.70

1.97

mpas

0.66

(3013166) Neutrophils/Leukocytes in Synovial fluid

108

406

1.36

2.28

1.3

48.55

56.46

1.29

349

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.96

2.23

1.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

174

1.56

2.23

1.9

1.7

1.77

1.80

mg/l

0.04

143

(40767503) Oxygen content in Capillary blood by calculation

718

4098

0.89

2.22

2.9

2.5

16.84

16.62

1.13

703

4010

(3035880) pH of Pleural fluid

203

835

1.24

2.21

1.3

1.2

7.40

0.22

147

551

(3009677) Dengue virus Ab [Presence] in Serum

1.90

2.16

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.11

2.14

1.0

1.2

11.50

24.83

umol/l

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

5.11

2.14

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

678

3092

1.12

2.13

1.4

1.3

3.28

3.98

ug/l

0.94

607

2824

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.87

2.08

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.76

2.07

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

522

2348

1.14

2.06

1.3

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

205

856

1.22

1.98

2.9

2.7

59.16

45.99

mg/l

0.26

135

592

(40760512) CD34 cells/cells in Bone marrow

4.38

1.94

1.5

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

4.38

1.94

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

136

1.58

1.91

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

2.02

1.89

1.1

1.0

0.45

0.07

u/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

146

591

1.26

1.88

1.0

0.31

0.72

u/ml

1.67

141

575

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2805

13636

1.05

1.86

4.3

3.8

1.23

1.22

mmol/l

0.76

2572

11412

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.87

1.85

1.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

5.11

1.84

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.11

1.84

1.0

1.2

—

(3039000) Anion gap in Blood by calculation

600

2747

1.12

1.82

8.0

5.8

11.53

11.36

mmol/l

0.61

544

2430

(3018572) Chloride [Moles/volume] in Blood

600

2748

1.12

1.81

8.0

5.8

105.03

104.96

mmol/l

0.14

545

2431

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

139

1.54

1.77

1.7

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

640

3618

0.90

1.74

1.7

1.6

—

(3041184) Isoniazid [Presence] in Urine

3.25

1.73

2.4

2.1

—

(3016750) Collection duration of Urine

194

820

1.21

1.72

2.2

2.0

492.43

502.00

min

0.67

177

549

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

195

1.44

1.69

2.0

1.5

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

2.04

1.65

1.1

1.0

0.89

0.08

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

109

1.59

1.65

1.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.26

1.64

1.0

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

4.26

1.64

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

4.26

1.64

1.0

1.2

—

(3004451) EKG impression Narrative

220

946

1.19

1.64

1.3

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

326

0.69

1.62

2.9

3.1

14.75

14.77

ml/dl

0.01

309

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.21

1.61

1.2

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.41

1.60

1.2

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

250

1.37

1.58

2.4

3.0

1290.50

1665.91

u/l

0.17

226

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1130

6194

0.93

1.54

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

120

1.53

1.51

1.2

95.45

106.26

ug/l

0.18

(3004446) Plasmodium sp identified in Blood by Light microscopy

209

1.39

1.50

2.8

2.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.43

1.50

2.3

2.1

24.12

25.90

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.43

1.50

1.5

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

253

1.35

1.48

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

512

2356

1.11

1.48

1.3

7.11

6.94

mmol/l

0.66

447

2096

(40758358) Immune stain study

1.95

1.48

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.89

1.45

1.0

0.51

0.06

u/ml

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

148

622

1.22

1.44

2.0

2.2

102.86

135.35

ug/min

0.21

118

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

213

927

1.17

1.42

1.2

10.12

9.83

mm/h

0.12

213

927

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

155

656

1.21

1.41

1.1

—

(3022670) pH of Venous cord blood

1.90

1.40

1.1

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.64

1.38

1.1

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

264

1175

1.15

1.34

1.0

1.1

0.70

0.77

u/ml

0.11

229

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.62

1.32

1.5

1.3

1.66

1.51

mg/l

0.27

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

199

1179

0.86

1.24

1.5

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.52

1.18

2.5

1.5

—

(3022475) Manganese [Moles/volume] in Blood

1.52

1.18

1.4

1.2

0.17

0.15

umol/l

0.89

(3034614) HLA Ag [Interpretation]

1.98

1.18

1.3

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

103

1.49

1.15

6.0

5.4

—

(40768795) Lymph node Pathology biopsy report

382

1765

1.11

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.62

1.10

1.1

1.5

1.17

1.14

u/field

0.04

(3046861) Legionella sp Ag [Presence] in Urine

145

0.63

1.08

1.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.55

1.07

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

296

1.26

1.05

6.8

5.4

6.08

5.27

kpa

1.23

296

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

377

1749

1.10

1.03

1.4

9.00

7.94

mmol/l

4.71

361

1668

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.80

1.00

1.1

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.74

0.99

1.0

1.1

4.56

4.88

mmol/l

0.19

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.53

0.98

1.3

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

146

641

1.16

0.97

2.7

3.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

461

2168

1.09

0.96

3.8

5.7

7.54

7.09

mmol/l

0.64

357

1801

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.56

0.88

1.1

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.75

0.87

4.7

5.9

0.15

0.21

mmol/l

0.50

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

259

0.77

0.84

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

408

2253

0.92

0.81

2.2

32.85

32.60

0.59

403

2238

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.63

0.81

1.1

1.0

7.72

8.77

mmol/l

1.25

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.40

0.78

1.0

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

268

1.22

0.76

1.0

1.1

2.60

8.63

u/ml

1.29

268

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

282

1.21

0.76

2.3

2.6

12.81

33.65

mg/l

3.46

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.62

0.75

1.1

1.0

7.18

15.91

mg/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1399

7431

0.96

0.74

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

218

1231

0.90

0.74

1.4

—

(3003577) Lead [Moles/volume] in Blood

174

1.26

0.70

1.1

1.6

0.11

0.40

umol/l

1.54

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.61

0.69

1.7

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.56

0.65

1.0

180.17

165.64

g/l

—

(4038314) Semen analysis, post vasectomy

181

1.24

0.64

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

321

1521

1.08

0.64

1.7

1.5

34.28

32.18

0.45

212

938

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.64

0.0

1.1

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.64

0.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

105

1.31

0.60

2.4

2.8

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.80

0.60

1.2

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

414

1.15

0.60

1.1

34.22

30.26

iu/ml

0.25

414

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

348

1.16

0.59

6.6

5.8

5.80

6.09

kpa

2.33

296

(3013762) Body weight Measured

1.60

0.56

1.0

1.2

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

152

0.77

0.53

1.3

1.4

72.08

69.56

0.15

124

(3001019) Free T4 and TSH panel - Serum or Plasma

2044

10191

1.03

0.51

1.7

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.63

0.51

1.1

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.44

0.50

1.1

1.0

—

mmol/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

335

1.14

0.49

1.9

2.7

7.62

7.24

mmol/l

0.30

169

(3010937) Rubella virus Ab [Presence] in Serum

133

1.23

0.46

1.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

1.50

0.46

3.5

6.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.50

0.46

1.0

260.70

302.07

u/l

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

108

497

1.11

0.45

4.7

2.2

5.00

4.93

kpa

0.23

108

497

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

108

497

1.11

0.45

4.7

2.2

10.44

10.38

kpa

0.07

108

497

(44786800) Granulocytes/Leukocytes in Body fluid

185

1.19

0.45

1.4

31.35

24.09

0.60

141

(3012565) Volume of 24 hour Urine

168

929

0.92

0.44

2.1

2.2

2066.81

2010.04

0.21

156

851

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.43

0.0

1.1

—

5.50

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.38

0.42

1.1

1.2

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

520

0.90

0.40

1.5

1.4

3.09

2.39

0.39

446

(46235168) Fasting glucose [Moles/volume] in Blood

255

1.14

0.39

2.1

7.27

7.04

mmol/l

0.15

(3025130) Human papilloma virus identified in Specimen

599

2953

1.04

0.36

1.8

—

(4281824) Cell count and differential, peritoneal fluid

349

1863

0.96

0.33

1.3

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

218

1.13

0.29

1.2

1.3

5.97

5.83

mmol/l

0.41

218

(3000919) Neutrophils/Leukocytes in Pleural fluid

451

0.92

0.29

1.4

24.93

22.02

0.40

411

(3001218) Citrate [Mass/time] in 24 hour Urine

1.32

0.29

1.5

1.4

492.88

408.19

mg/24h

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

340

1.10

0.29

1.4

1.2

73.79

67.33

ug/l

0.38

340

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

0.67

0.27

1.4

1.2

0.00

0.63

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

147

1.15

0.27

1.1

1.38

1.17

mom

0.93

147

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

143

0.86

0.26

2.4

1.9

22.35

19.33

0.19

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.28

0.23

1.4

1.0

2.00

1.40

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

114

549

1.06

0.22

1.5

1.4

59.46

63.47

0.57

467

(3041806) Other cells [#/volume] in Blood by Manual count

178

951

0.96

0.21

1.7

1.4

0.53

0.51

e9/l

0.49

178

951

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

136

1.13

0.20

1.1

16.67

17.20

iu/ml

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

284

1.08

0.19

1.2

1.43

1.66

mmol/l

0.65

167

(3035320) C reactive protein [Mass/volume] in Body fluid

277

1370

1.03

0.19

3.2

2.2

27.88

28.58

mg/l

0.10

196

972

(3000012) Reticulocyte production index

491

2451

1.02

0.18

1.9

2.2

0.96

0.90

1.38

332

1626

(3001729) Color of Synovial fluid

128

1.12

0.17

1.2

1.6

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

242

1.08

0.16

1.6

1.4

14.87

10.56

0.57

141

(3021706) Oxygen [Partial pressure] in Arterial cord blood

142

0.90

0.15

1.0

2.66

3.70

kpa

2.06

120

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

312

1557

1.02

0.14

1.5

1.6

8.23

7.52

mmol/l

5.01

297

1503

(3051101) Glucose [Moles/volume] in Cord blood

294

1.06

0.14

4.8

6.0

9.67

8.39

mmol/l

0.81

294

(3011544) Albumin [Mass/volume] in Pleural fluid

197

0.93

0.11

1.1

1.2

15.41

17.88

g/l

0.81

180

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.89

0.11

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

222

1.06

0.10

1.3

1.2

2.69

1.27

mmol/l

0.47

137

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.06

0.09

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

218

1137

0.98

0.09

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

216

0.95

0.09

7.2

6.1

10.78

10.73

0.04

216

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

162

0.95

0.07

2.1

51.32

58.52

0.57

101

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

258

1334

0.99

0.05

1.3

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

145

0.95

0.05

1.0

7.73

7.34

kpa

0.50

124

(3006598) pH of Arterial cord blood

145

0.95

0.05

1.0

—

(4212803) Bone marrow aspirate examination

121

1.06

0.05

1.2

1.0

—

(3034891) Synovial lining cells/cells in Synovial fluid

159

823

0.99

0.04

1.7

1.4

4.16

4.54

0.09

204

(3005082) Progesterone [Moles/volume] in Serum or Plasma

248

1279

0.99

0.04

1.4

30.09

34.39

nmol/l

1.30

218

1199

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

257

0.97

0.03

3.7

5.3

51.77

47.36

ug/min

0.13

207

(3004959) Base excess in Arterial cord blood by calculation

142

0.97

0.01

1.0

-0.83

-1.50

mmol/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

311

0.99

0.01

1.3

1.2

170.35

54.82

mg/l

0.59

218

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

121

1.01

0.00

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

218

1.01

0.00

1.2

20.22

20.54

mmol/l

0.17

180

(3011325) HIV 1+2 Ab [Presence] in Serum

100

0.97

0.00

1.0

0.10

0.08

0.34

(3035611) Eosinophils/Leukocytes in Synovial fluid

114

0.99

0.00

1.2

1.7

0.95

0.64

0.17

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.97

0.00

1.4

1.0

322.57

246.83

u/ml

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.02

0.00

2.6

2.4

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.91

-0.00

1.2

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.96

-0.00

1.0

1.1

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

10.68

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.91

-0.00

1.1

1.3

22.71

33.04

mg/24h

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI – Medical observation and evaluation for suspected diseases and conditions

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Medical observation and evaluation for suspected diseases and conditions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Medical observation and evaluation for suspected diseases and conditions (Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints